Extracellular-regulated	B-protein
kinase	I-protein
1/2	I-protein
,	O
Jun	B-protein
N-terminal	I-protein
kinase	I-protein
,	O
and	O
c-Jun	B-protein
are	O
involved	O
in	O
NF-kappa	B-protein
B	I-protein
-dependent	O
IL-6	B-protein
expression	O
in	O
human	O
monocytes	O
.	O

In	O
the	O
present	O
study	O
we	O
investigated	O
the	O
possible	O
involvement	O
of	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
family	I-protein
members	O
extracellular-regulated	B-protein
kinase	I-protein
1/2	I-protein
(	O
ERK1/2	B-protein
)	O
and	O
c-	O
Jun	B-protein
N-terminal	I-protein
kinase	I-protein
(	O
JNK	B-protein
)	O
in	O
mediating	O
IL-6	B-protein
gene	O
expression	O
in	O
human	B-cell_type
monocytes	I-cell_type
,	O
in	O
particular	O
their	O
role	O
in	O
enhancing	O
NF-kappa	B-protein
B	I-protein
activity	O
.	O

Freshly	O
isolated	O
monocytes	O
treated	O
with	O
the	O
protein	O
phosphatase	O
inhibitor	O
okadaic	O
acid	O
secreted	O
high	O
levels	O
of	O
IL-6	B-protein
protein	I-protein
,	O
which	O
coincided	O
with	O
enhanced	O
binding	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
as	O
well	O
as	O
with	O
phosphorylation	O
and	O
activation	O
of	O
the	O
ERK1/2	B-protein
and	I-protein
JNK	I-protein
proteins	I-protein
.	O

The	O
ERK	O
pathway-specific	O
inhibitor	O
PD98059	O
inhibited	O
IL-6	B-protein
secretion	O
from	O
monocytes	B-cell_type
.	O

Transient	O
overexpression	O
of	O
inactive	O
mutants	O
of	O
either	O
Raf-1	B-protein
or	O
JNK1	B-protein
showed	O
that	O
both	O
pathways	O
were	O
involved	O
in	O
kappa	O
B-dependent	O
IL-6	B-protein
promoter	O
activity	O
.	O

By	O
using	O
PD98059	O
,	O
we	O
demonstrated	O
that	O
the	O
Raf1/MEK1/	O
ERK1/2	B-protein
pathway	O
did	O
not	O
affect	O
the	O
DNA	O
binding	O
of	O
NF-kappa	B-protein
B	I-protein
but	O
,	O
rather	O
,	O
acted	O
at	O
the	O
level	O
of	O
transcriptional	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

Interestingly	O
,	O
it	O
was	O
shown	O
that	O
NF-kappa	B-protein
B	I-protein
-mediated	O
gene	O
transcription	O
,	O
both	O
in	O
the	O
context	O
of	O
the	O
IL-6	B-DNA
promoter	I-DNA
as	O
well	O
as	O
on	O
its	O
own	O
,	O
was	O
dependent	O
on	O
both	O
serine	O
kinase	O
activity	O
and	O
interaction	O
with	O
c-Jun	B-protein
protein	I-protein
.	O

We	O
conclude	O
that	O
okadaic	O
acid-induced	O
IL-6	B-protein
gene	O
expression	O
is	O
at	O
least	O
partly	O
mediated	O
through	O
the	O
ERK1/2	B-protein
and	O
JNK	B-protein
pathway-dependent	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
transcriptional	O
capacity	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
JNK	B-protein
pathway	O
may	O
regulate	O
NF-kappa	B-protein
B	I-protein
-mediated	O
gene	O
transcription	O
through	O
its	O
phosphorylation	O
and	O
activation	O
of	O
c-Jun	B-protein
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
F	NULL
3	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
T	NULL
‘	NULL
.CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
#	NULL
s	NULL
meJournal	NULL
of	NULL
Extracellular-Regulated	NULL
Kinase	NULL
1/2	NULL
,	NULL
Jun	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
N-Terminal	NULL
Kinase	NULL
,	NULL
and	NULL
c-Jun	NULL
Are	NULL
.	NULL

Imfolved	NULL
in	NULL
NF-	NULL
<	NULL
xB-Dependent	NULL
IL-6	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Leonore	NULL
M.	NULL
L.	NULL
Tuyt	NULL
,	NULL
Wim	NULL
H.	NULL
A.	NULL
Dokter	NULL
,	NULL
Kim	NULL
Birkenkamp	NULL
,	NULL
Sicco	NULL
B.	NULL
Koopmans	NULL
,	NULL
Chantal	NULL
Lummen	NULL
,	NULL
Wiebe	NULL
Krujjer	NULL
and	NULL
Edo	NULL
Vellenga	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:4893-4902	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4893	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
55	NULL
articles	NULL
,	NULL
25	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/8/4893	NULL
.	NULL

full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Extracellular-Regulated	NULL
Kinase	NULL
1/2	NULL
,	NULL
Jun	NULL
N-Terminal	NULL
Kinase	NULL
,	NULL
and	NULL
c-Jun	NULL
Are	NULL
Involved	NULL
in	NULL
NF-B-Dependent	NULL
IL-6	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
'	NULL
Leonore	NULL
M.	NULL
L.	NULL
Tuyt	NULL
,	NULL
*	NULL
Wim	NULL
H.	NULL
A.	NULL
Dokter	NULL
,	NULL
``	NULL
*	NULL
Kim	NULL
Birkenkamp	NULL
,	NULL
**	NULL
Sicco	NULL
B.	NULL
Koopmans	NULL
,	NULL
*	NULL
Chantal	NULL
Lummen	NULL
,	NULL
*	NULL
Wiebe	NULL
Kruijer	NULL
,	NULL
'	NULL
and	NULL
Edo	NULL
Vellenga**	NULL
In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
investigated	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
family	NULL
members	NULL
extracellular-regulated	NULL
kinase	NULL
1/2	NULL
(	NULL
ERK1/2	NULL
)	NULL
and	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
in	NULL
mediating	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
in	NULL
particular	NULL
their	NULL
role	NULL
in	NULL
enhancing	NULL
NF-KB	NULL
activity	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
treated	NULL
with	NULL
the	NULL
protein	NULL
phosphatase	NULL
inhibitor	NULL
okadaic	NULL
acid	NULL
secreted	NULL
high	NULL
levels	NULL
of	NULL
IL-6	NULL
protein	NULL
,	NULL
which	NULL
coincided	NULL
with	NULL
enhanced	NULL
binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
as	NULL
well	NULL
as	NULL
with	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
ERK1/2	NULL
and	NULL
JNK	NULL
proteins	NULL
.	NULL

The	NULL
ERK	NULL
pathway-specific	NULL
inhibitor	NULL
PD98059	NULL
inhibited	NULL
IL-6	NULL
secretion	NULL
from	NULL
monocytes	NULL
.	NULL

Transient	NULL
overexpression	NULL
of	NULL
inactive	NULL
mutants	NULL
of	NULL
either	NULL
Raf-1	NULL
or	NULL
JNK1	NULL
showed	NULL
that	NULL
both	NULL
pathways	NULL
were	NULL
involved	NULL
in	NULL
B-dependent	NULL
IL-6	NULL
promoter	NULL
activity	NULL
.	NULL

By	NULL
using	NULL
PD98059	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
RafL/MEK1/ERK1/2	NULL
pathway	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NF-KB	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
acted	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
NF-B-mediated	NULL
gene	NULL
transcription	NULL
,	NULL
both	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
as	NULL
well	NULL
as	NULL
on	NULL
its	NULL
own	NULL
,	NULL
was	NULL
dependent	NULL
on	NULL
both	NULL
serine	NULL
kinase	NULL
activity	NULL
and	NULL
interaction	NULL
with	NULL
c-Jun	NULL
protein	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
okadaic	NULL
acid-induced	NULL
IL-6	NULL
gene	NULL
expression	NULL
is	NULL
at	NULL
least	NULL
partly	NULL
mediated	NULL
through	NULL
the	NULL
ERK1/2	NULL
and	NULL
JNK	NULL
pathway-dependent	NULL
activation	NULL
of	NULL
NF-B	NULL
transcriptional	NULL
capacity	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
JNK	NULL
pathway	NULL
may	NULL
regulate	NULL
NF-B-mediated	NULL
gene	NULL
transcription	NULL
through	NULL
its	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
c-Jun	NULL
.	NULL

-The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
4893-4902.	NULL
xpression	NULL
of	NULL
IL-6	NULL
in	NULL
monocytes	NULL
is	NULL
mainly	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
1-8	NULL
)	NULL
.	NULL

In	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
five	NULL
known	NULL
functional	NULL
cis-regulatory	NULL
elements	NULL
have	NULL
been	NULL
described	NULL
,	NULL
namely	NULL
cAMP-responsive	NULL
element	NULL
,	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
,	NULL
*	NULL
nuclear	NULL
factor	NULL
IL-6	NULL
(	NULL
NF-IL6	NULL
)	NULL
,	NULL
Spl	NULL
,	NULL
and	NULL
NF-KB	NULL
binding	NULL
sites	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
regulator	NULL
of	NULL
IL-6	NULL
gene	NULL
transcription	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
1.2-kb	NULL
fragment	NULL
of	NULL
the	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
the	NULL
functional	NULL
NF-	NULL
«	NULL
B	NULL
element	NULL
is	NULL
located	NULL
between	NULL
positions	NULL
-73	NULL
and	NULL
-63	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
complexes	NULL
consist	NULL
of	NULL
members	NULL
of	NULL
the	NULL
rel	NULL
multigene	NULL
family	NULL
,	NULL
which	NULL
is	NULL
comprised	NULL
of	NULL
five	NULL
major	NULL
proteins	NULL
:	NULL
p50	NULL
,	NULL
p65	NULL
(	NULL
Rel	NULL
A	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
p52	NULL
,	NULL
and	NULL
Rel	NULL
B	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

The	NULL
most	NULL
abundant	NULL
dimer	NULL
is	NULL
the	NULL
p50/p65	NULL
NF-	NULL
«	NULL
B	NULL
heterodimer	NULL
.	NULL

NF-KB	NULL
is	NULL
located	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
an	NULL
inducible	NULL
form	NULL
,	NULL
in	NULL
which	NULL
the	NULL
heterodimer	NULL
is	NULL
com-plexed	NULL
to	NULL
the	NULL
inhibitory	NULL
subunit	NULL
,	NULL
I	NULL
«	NULL
Ba	NULL
.	NULL

Upon	NULL
stimulation	NULL
of	NULL
the	NULL
cell	NULL
,	NULL
IkBa	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
;	NULL
the	NULL
released	NULL
nucleo-	NULL
*Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
'Division	NULL
of	NULL
Developmental	NULL
Genetics	NULL
,	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Groningen	NULL
,	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
Received	NULL
for	NULL
publication	NULL
July	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
22	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
RUG	NULL
94-788	NULL
from	NULL
the	NULL
Dutch	NULL
Cancer	NULL
Foundation	NULL
.	NULL

*	NULL
Present	NULL
address	NULL
:	NULL
Akzo	NULL
Nobel	NULL
,	NULL
N.V.	NULL
Organon	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
20	NULL
,	NULL
5340	NULL
BH	NULL
Oss	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

3	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Edo	NULL
Vellenga	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
Hospital	NULL
Groningen	NULL
,	NULL
Hanzeplein	NULL
1	NULL
,	NULL
9713	NULL
GZ	NULL
Groningen	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
e.vellenga	NULL
@	NULL
int.azg.nl	NULL
*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
NF-IL6	NULL
,	NULL
nuclear	NULL
factor	NULL
IL-6	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
regulated	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
SAPK	NULL
,	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
;	NULL
IKK	NULL
,	NULL
IKB	NULL
kinase	NULL
;	NULL
PPase	NULL
,	NULL
protein	NULL
phosphatase	NULL
;	NULL
OA	NULL
,	NULL
okadaic	NULL
acid	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
de-hydrogenase	NULL
;	NULL
EMSA	NULL
,	NULL
electromobility	NULL
shift	NULL
assay	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
philic	NULL
heterodimer	NULL
then	NULL
moves	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Both	NULL
p50	NULL
and	NULL
p65	NULL
contribute	NULL
to	NULL
NE-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
,	NULL
but	NULL
only	NULL
the	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
transactivation	NULL
.	NULL

Although	NULL
simultaneous	NULL
activity	NULL
of	NULL
NF-KB	NULL
and	NULL
additional	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
NF-IL6/CEBP	NULL
,	NULL
is	NULL
required	NULL
to	NULL
maximally	NULL
induce	NULL
IL-6	NULL
gene	NULL
transcription	NULL
,	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
«	NULL
B	NULL
regulatory	NULL
element	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
appears	NULL
most	NULL
prominent	NULL
(	NULL
5-8	NULL
,	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Much	NULL
progress	NULL
has	NULL
been	NULL
made	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
involved	NULL
in	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Of	NULL
great	NULL
importance	NULL
are	NULL
the	NULL
so-called	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
proteins	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
different	NULL
MAPK	NULL
signaling	NULL
pathways	NULL
ultimately	NULL
results	NULL
in	NULL
the	NULL
direct	NULL
or	NULL
indirect	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
various	NULL
transcription	NULL
factors	NULL
and	NULL
alterations	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

Although	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
MAPK	NULL
pathways	NULL
in	NULL
IL-6	NULL
gene	NULL
regulation	NULL
in	NULL
human	NULL
monocytes	NULL
is	NULL
far	NULL
from	NULL
elucidated	NULL
,	NULL
there	NULL
are	NULL
several	NULL
observations	NULL
from	NULL
other	NULL
cell	NULL
systems	NULL
that	NULL
may	NULL
indicate	NULL
a	NULL
functional	NULL
role	NULL
for	NULL
the	NULL
individual	NULL
kinase	NULL
pathways	NULL
in	NULL
activating	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
in	NULL
COS	NULL
cells	NULL
p90®°°	NULL
%	NULL
,	NULL
the	NULL
downstream	NULL
kinase	NULL
of	NULL
Raf-1/MEK1/ERK1/2	NULL
pathway	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
the	NULL
N-terminal	NULL
regulatory	NULL
domain	NULL
of	NULL
I	NULL
«	NULL
kBa	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
only	NULL
after	NULL
12-O-tetraphorbol	NULL
12-myristate	NULL
13-acetate	NULL
stimulation	NULL
,	NULL
and	NULL
thus	NULL
enhance	NULL
NF-kB	NULL
DNA-binding	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
,	NULL
in	NULL
the	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
CEM	NULL
,	NULL
overexpression	NULL
of	NULL
either	NULL
MEK	NULL
1	NULL
or	NULL
ERK1	NULL
demonstrated	NULL
constitutive	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-KB	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
classical	NULL
ERK	NULL
pathway	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
c-Jun	NULL
NH-terminal	NULL
kinase/stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
JNK/SAPK	NULL
)	NULL
pathway	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
small	NULL
GTP-binding	NULL
proteins	NULL
,	NULL
including	NULL
cdc42	NULL
and	NULL
Racl	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
downstream	NULL
kinase	NULL
MEKK1	NULL
is	NULL
activated	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
activates	NULL
MKK4	NULL
,	NULL
the	NULL
upstream	NULL
kinase	NULL
of	NULL
JNK	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
sub-strates	NULL
of	NULL
JNK	NULL
are	NULL
c-Jun	NULL
,	NULL
activating	NULL
transcription	NULL
factor-2	NULL
,	NULL
and	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4894	NULL
Elk-1	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
overexpression	NULL
in	NULL
T	NULL
cells	NULL
of	NULL
an	NULL
active	NULL
form	NULL
of	NULL
MEKK1	NULL
,	NULL
a	NULL
constitutive	NULL
activator	NULL
of	NULL
JNK	NULL
,	NULL
results	NULL
in	NULL
the	NULL
direct	NULL
activation	NULL
of	NULL
the	NULL
IxBa	NULL
kinase	NULL
,	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
NF-KB	NULL
reporter	NULL
gene	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
HeLa	NULL
cells	NULL
MEKK1	NULL
was	NULL
shown	NULL
to	NULL
directly	NULL
activate	NULL
the	NULL
IxBa	NULL
kinase	NULL
(	NULL
IKK	NULL
)	NULL
complex	NULL
in	NULL
vitro	NULL
,	NULL
which	NULL
,	NULL
through	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxB	NULL
,	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
20	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
indicate	NULL
a	NULL
link	NULL
between	NULL
NF-KB	NULL
and	NULL
the	NULL
JNK	NULL
signaling	NULL
cascade	NULL
.	NULL

The	NULL
question	NULL
remains	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
the	NULL
above	NULL
mentioned	NULL
signaling	NULL
pathways	NULL
are	NULL
also	NULL
operational	NULL
in	NULL
monocytes	NULL
with	NULL
respect	NULL
to	NULL
«	NULL
B-mediated	NULL
IL-6	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
wanted	NULL
to	NULL
further	NULL
identify	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
ERK1/2	NULL
and	NULL
JNK	NULL
pathways	NULL
in	NULL
mediating	NULL
«	NULL
B-dependent	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

One	NULL
tool	NULL
in	NULL
studies	NULL
of	NULL
the	NULL
importance	NULL
of	NULL
phosphorylation	NULL
states	NULL
of	NULL
signaling	NULL
molecules	NULL
is	NULL
the	NULL
use	NULL
of	NULL
specific	NULL
pharmacologic	NULL
inhibitors	NULL
of	NULL
protein	NULL
phosphatases	NULL
(	NULL
PPases	NULL
)	NULL
.	NULL

Opposite	NULL
of	NULL
the	NULL
protein	NULL
kinases	NULL
,	NULL
the	NULL
PPases	NULL
regulate	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
key	NULL
proteins	NULL
by	NULL
removing	NULL
the	NULL
phosphate	NULL
group	NULL
from	NULL
the	NULL
tyrosine	NULL
,	NULL
serine	NULL
,	NULL
or	NULL
threonine	NULL
residues	NULL
of	NULL
activated	NULL
proteins	NULL
.	NULL

Okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
,	NULL
a	NULL
polyether	NULL
fatty	NULL
acid	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
the	NULL
phosphoserine	NULL
and	NULL
phosphothreonine	NULL
phosphatases	NULL
PP1	NULL
and	NULL
PP2A	NULL
(	NULL
21	NULL
)	NULL
.	NULL

OA	NULL
is	NULL
known	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
stimu-lator	NULL
of	NULL
IL-1	NULL
and	NULL
TNF-a	NULL
production	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
OA	NULL
on	NULL
the	NULL
ERK1/2	NULL
and	NULL
JNK	NULL
signaling	NULL
pathways	NULL
and	NULL
their	NULL
involvement	NULL
in	NULL
NF-	NULL
«	NULL
B-driven	NULL
IL-6	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Our	NULL
results	NULL
provide	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Ras/Raf-1/ERK1/2	NULL
pathway	NULL
,	NULL
the	NULL
JNK	NULL
pathway	NULL
,	NULL
and	NULL
the	NULL
c-Jun	NULL
protein	NULL
in	NULL
NF-	NULL
«	NULL
B-mediated	NULL
IL-6	NULL
gene	NULL
regulation	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
RPMI	NULL
1640	NULL
medium	NULL
was	NULL
purchased	NULL
from	NULL
Flow	NULL
Laboratories	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
FBS	NULL
was	NULL
obtained	NULL
from	NULL
HyClone	NULL
(	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
and	NULL
Lymphoprep	NULL
was	NULL
obtained	NULL
from	NULL
Nycomed	NULL
(	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

OA	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Radionucleotides	NULL
were	NULL
obtained	NULL
from	NULL
Amersham	NULL
(	NULL
Aylesbury	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Abs	NULL
against	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
and	NULL
JNK1	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
the	NULL
anti-CD14	NULL
was	NULL
obtained	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
MEK1	NULL
inhibitor	NULL
PDO98059	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

cDNA	NULL
probe	NULL
for	NULL
IL-6	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
L.	NULL
Aarden	NULL
(	NULL
Central	NULL
Laboratory	NULL
of	NULL
The	NULL
Netherlands	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
.	NULL

GST-c-Jun	NULL
fusion	NULL
protein	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Borst	NULL
(	NULL
The	NULL
Netherlands	NULL
Cancer	NULL
Institute	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
.	NULL

ELISA	NULL
kits	NULL
for	NULL
IL-6	NULL
(	NULL
Pelikine	NULL
Compac	NULL
kits	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
CLB	NULL
(	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
and	NULL
anti-TNF-	NULL
was	NULL
obtained	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
(	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
detection	NULL
kit	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
IL-3	NULL
was	NULL
received	NULL
from	NULL
Genetics	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

All	NULL
IL-6	NULL
promoter	NULL
constructs	NULL
,	NULL
containing	NULL
various	NULL
portions	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
promoter	NULL
cloned	NULL
into	NULL
the	NULL
pGL	NULL
,	NULL
luciferase	NULL
reporter	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
were	NULL
generated	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

pGAL4-p65	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
(	NULL
Tularik	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
pGAL4-dbd	NULL
and	NULL
pGALA4tkluc	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
S.	NULL
Wissink	NULL
(	NULL
NIOB	NULL
,	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
.	NULL

pRSV-NARafl	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
P.	NULL
J.	NULL
Coffer	NULL
(	NULL
Department	NULL
of	NULL
Pulmonary	NULL
Diseases	NULL
,	NULL
University	NULL
Hospital	NULL
Utrecht	NULL
,	NULL
Utrecht	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
,	NULL
pcDNA3-Flag-JNK	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
J.	NULL
Davis	NULL
(	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Massachusetts	NULL
Medical	NULL
School	NULL
,	NULL
Worchester	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

pCMV-TAM67	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
M.	NULL
J.	NULL
Birrer	NULL
(	NULL
Biomarkers	NULL
and	NULL
Prevention	NULL
Research	NULL
Branch	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
3xCAT	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Hiscott	NULL
(	NULL
The	NULL
Sir	NULL
Mortimer	NULL
B.	NULL
Davis-Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
Montreal	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
monocytes	NULL
and	NULL
cell	NULL
culture	NULL
Peripheral	NULL
blood	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteer	NULL
platelet	NULL
do-nors	NULL
,	NULL
and	NULL
mononuclear	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
by	NULL
Ficoll-Hypaque	NULL
density-gradient	NULL
centrifugation	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
depleted	NULL
by	NULL
2-amin-oethylisothiouronium	NULL
bromide-treated	NULL
SRBC	NULL
rosetting	NULL
.	NULL

Monocytes	NULL
were	NULL
further	NULL
enriched	NULL
by	NULL
plastic	NULL
adherence	NULL
(	NULL
1	NULL
h	NULL
,	NULL
37°C	NULL
)	NULL
and	NULL
demonstrated	NULL
a	NULL
purity	NULL
of	NULL
>	NULL
95	NULL
%	NULL
,	NULL
detected	NULL
by	NULL
FACS	NULL
analysis	NULL
with	NULL
anti-CD14	NULL
Ab	NULL
.	NULL

Monocytes	NULL
were	NULL
ERK1/2	NULL
,	NULL
JNK	NULL
,	NULL
AND	NULL
c-Jun	NULL
IN	NULL
NF-	NULL
«	NULL
B-MEDIATED	NULL
IL-6	NULL
EXPRESSION	NULL
cultured	NULL
at	NULL
37°C	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1-2	NULL
X	NULL
10°/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
6	NULL
ng/ml	NULL
colistine	NULL
,	NULL
and	NULL
the	NULL
appropriate	NULL
amount	NULL
of	NULL
FBS	NULL
.	NULL

The	NULL
cell	NULL
line	NULL
employed	NULL
in	NULL
these	NULL
studies	NULL
was	NULL
TE-1	NULL
,	NULL
a	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
TF-1	NULL
cell	NULL
line	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FBS	NULL
and	NULL
10	NULL
ng/ml	NULL
IL-3	NULL
.	NULL

The	NULL
toxicity	NULL
of	NULL
OA	NULL
was	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
assays	NULL
.	NULL

IL-6	NULL
protein	NULL
determination	NULL
Freshly	NULL
isolated	NULL
monocytes	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
1	NULL
ml	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
.	NULL

Sixteen	NULL
hours	NULL
after	NULL
the	NULL
adherence	NULL
step	NULL
,	NULL
medium	NULL
was	NULL
replaced	NULL
by	NULL
1	NULL
ml	NULL
of	NULL
fresh	NULL
RPMI	NULL
1640	NULL
containing	NULL
2	NULL
%	NULL
FBS	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
subsequently	NULL
stimulated	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
treatment	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
!	NULL
)	NULL

the	NULL
cell-free	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
secreted	NULL
IL-6	NULL
protein	NULL
by	NULL
ELISA	NULL
.	NULL

Experiments	NULL
with	NULL
the	NULL
MEK1	NULL
inhibitor	NULL
PD98059	NULL
were	NULL
performed	NULL
by	NULL
pretreatment	NULL
of	NULL
monocytes	NULL
for	NULL
30	NULL
min	NULL
with	NULL
10	NULL
uM	NULL
PD98059	NULL
before	NULL
stimulation	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
monocytes	NULL
were	NULL
preincubated	NULL
with	NULL
TNF-a	NULL
or	NULL
IL-18B	NULL
Ab	NULL
before	NULL
OA	NULL
stimulation	NULL
(	NULL
1/1000	NULL
diluted	NULL
polyclonal	NULL
antiserum	NULL
against	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
B	NULL
was	NULL
maximally	NULL
effective	NULL
,	NULL
as	NULL
studied	NULL
with	NULL
in	NULL
vitro	NULL
dose-response	NULL
curves	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assay	NULL
The	NULL
run-on	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
using	NULL
40	NULL
X	NULL
10°	NULL
monocytes/reaction	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
for	NULL
16	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
medium	NULL
or	NULL
medium	NULL
plus	NULL
OA	NULL
for	NULL
1	NULL
or	NULL
7	NULL
h	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
the	NULL
following	NULL
DNAs	NULL
were	NULL
immobilized	NULL
on	NULL
Hybond	NULL
N+	NULL
membranes	NULL
(	NULL
Amersham	NULL
)	NULL
:	NULL
1	NULL
)	NULL
EcoRL-linearized	NULL
pGEM	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
,	NULL
2	NULL
)	NULL
EcoR-linearized	NULL
plasmid	NULL
containing	NULL
a	NULL
1.3-kb	NULL
fragment	NULL
of	NULL
the	NULL
rat	NULL
GAPDH	NULL
cDNA	NULL
,	NULL
and	NULL
3	NULL
)	NULL
EcoRI-linearized	NULL
plasmid	NULL
containing	NULL
a	NULL
0.3-kb	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
cDNA	NULL
.	NULL

Hybridization	NULL
of	NULL
labeled	NULL
RNAs	NULL
to	NULL
these	NULL
membranes	NULL
was	NULL
performed	NULL
at	NULL
65°C	NULL
for	NULL
18	NULL
h	NULL
in	NULL
0.5	NULL
mol/l	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
7	NULL
%	NULL
SDS	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
washed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-OMAT	NULL
XAR	NULL
films	NULL
(	NULL
East-man	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-80°C	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Quan-titation	NULL
of	NULL
the	NULL
newly	NULL
synthesized	NULL
RNAs	NULL
was	NULL
performed	NULL
by	NULL
phosphorimaging	NULL
(	NULL
PhosphorImager	NULL
,	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
after	NULL
normalization	NULL
to	NULL
the	NULL
GAPDH	NULL
signal	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
After	NULL
overnight	NULL
culture	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
monocytes	NULL
were	NULL
stimulated	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
miniscale	NULL
procedure	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
divided	NULL
into	NULL
small	NULL
aliquots	NULL
and	NULL
were	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Double-stranded	NULL
synthetic	NULL
oligonucleotide	NULL
probes	NULL
containing	NULL
the	NULL
NFE-	NULL
«	NULL
B	NULL
consensus	NULL
sequences	NULL
(	NULL
NF-KB	NULL
,	NULL
5-AGCTGCGGGGATTTTCCCTG-3	NULL
'	NULL
)	NULL
was	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
.	NULL

The	NULL
consensus	NULL
sequence	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
is	NULL
underlined	NULL
.	NULL

Fifty	NULL
nanograms	NULL
of	NULL
HPLC-purified	NULL
single-stranded	NULL
oligonucleotide	NULL
was	NULL
labeled	NULL
with	NULL
T4-polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
7y-°P	NULL
]	NULL
ATP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
,	NULL
separated	NULL
from	NULL
nonincorporated	NULL
radiolabel	NULL
by	NULL
Seph-adex	NULL
G-50	NULL
chromatography	NULL
,	NULL
ethanol	NULL
precipitated	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
dissolved	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
containing	NULL
a	NULL
4-fold	NULL
excess	NULL
of	NULL
the	NULL
opposite	NULL
strand	NULL
.	NULL

Annealing	NULL
of	NULL
the	NULL
two	NULL
strands	NULL
was	NULL
performed	NULL
by	NULL
heating	NULL
the	NULL
mixture	NULL
for	NULL
2	NULL
min	NULL
at	NULL
90°C	NULL
and	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extract	NULL
and	NULL
0.1	NULL
ng	NULL
of	NULL
double-stranded	NULL
labeled	NULL
oligonucleotide	NULL
were	NULL
incubated	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
0.06	NULL
mM	NULL
EDTA	NULL
,	NULL
0.6	NULL
mM	NULL
DTT	NULL
,	NULL
2	NULL
mM	NULL
spermidine	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
supplemented	NULL
with	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
at	NULL
26°C	NULL
for	NULL
25	NULL
min	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
adding	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
self	NULL
or	NULL
nonself	NULL
double-stranded	NULL
oligonucleotides	NULL
.	NULL

Supershift	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
nuclear	NULL
extracts	NULL
and	NULL
labeled	NULL
oligonucleotide	NULL
with	NULL
polyclonal	NULL
Abs	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
against	NULL
the	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p52	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
loaded	NULL
on	NULL
prerun	NULL
(	NULL
30	NULL
min	NULL
,	NULL
100	NULL
V	NULL
)	NULL
4	NULL
%	NULL
(	NULL
30/1	NULL
)	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
run	NULL
for	NULL
1	NULL
h	NULL
at	NULL
150	NULL
V	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
films	NULL
at	NULL
-80°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Quantification	NULL
of	NULL
protein	NULL
binding	NULL
was	NULL
performed	NULL
by	NULL
densitometry	NULL
using	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
The	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
pILéluc	NULL
(	NULL
-602	NULL
)	NULL
,	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
,	NULL
and	NULL
plLéluc	NULL
(	NULL
-60	NULL
)	NULL
,	NULL
containing	NULL
various	NULL
portions	NULL
of	NULL
the	NULL
human	NULL
IL-6	NULL
promoter	NULL
cloned	NULL
into	NULL
the	NULL
pGL	NULL
,	NULL
luciferase	NULL
reporter	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
TF-1	NULL
cell	NULL
line	NULL
by	NULL
means	NULL
of	NULL
electroporation	NULL
.	NULL

Before	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
at	NULL
a	NULL
density	NULL
of	NULL
0.5	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
the	NULL
appropriate	NULL
medium	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
at	NULL
a	NULL
density	NULL
of	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
10	NULL
X	NULL
10	NULL
%	NULL
in	NULL
200	NULL
ul	NULL
.	NULL

When	NULL
transfected	NULL
with	NULL
a	NULL
single	NULL
plasmid	NULL
25	NULL
ug	NULL
of	NULL
DNA	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
left	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cotransfections	NULL
were	NULL
performed	NULL
with	NULL
15	NULL
pug	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
(	NULL
plLéluc	NULL
(	NULL
-602	NULL
)	NULL
,	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
,	NULL
or	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
3xCAT	NULL
)	NULL
together	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
the	NULL
expression	NULL
plasmid	NULL
(	NULL
pRSV-NARafl	NULL
,	NULL
peDNA3-Flag-JNK1	NULL
,	NULL
pCMV-TAM67	NULL
,	NULL
or	NULL
peDNA3	NULL
empty	NULL
vector	NULL
)	NULL
Cotransfections	NULL
of	NULL
pGALAtkluc	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
with	NULL
either	NULL
pGAL4-p65	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
or	NULL
pGAL4-dbd	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
performed	NULL
under	NULL
similar	NULL
conditions	NULL
.	NULL

Electroporation	NULL
,	NULL
in	NULL
0.4-cm	NULL
electroporation	NULL
cuvettes	NULL
,	NULL
was	NULL
performed	NULL
at	NULL
240	NULL
V	NULL
and	NULL
960	NULL
pF	NULL
with	NULL
a	NULL
Gene	NULL
Pulser	NULL
electroporator	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

After	NULL
electroporation	NULL
the	NULL
cells	NULL
were	NULL
replated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
2	NULL
%	NULL
FBS	NULL
.	NULL

Six	NULL
hours	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
lysed	NULL
by	NULL
commercially	NULL
available	NULL
luciferase	NULL
lysis	NULL
buffer	NULL
.	NULL

One	NULL
hundred	NULL
microliters	NULL
of	NULL
lysis	NULL
product	NULL
were	NULL
added	NULL
to	NULL
100	NULL
pl	NULL
of	NULL
luciferase	NULL
assay	NULL
reagents	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
the	NULL
Anthos	NULL
Lucy	NULL
]	NULL
luminometer	NULL
(	NULL
Anthos	NULL
Labtec	NULL
Instru-ments	NULL
,	NULL
Salzburg	NULL
,	NULL
Austria	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
for	NULL
ERK1	NULL
and	NULL
ERK2	NULL
Phosphorylation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Briefly	NULL
,	NULL
monocytes	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
FBS	NULL
and	NULL
subsequently	NULL
stimulated	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
harvesting	NULL
,	NULL
total	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspending	NULL
the	NULL
cells	NULL
in	NULL
500	NULL
ul	NULL
of	NULL
1	NULL
X	NULL
sample	NULL
buffer	NULL
(	NULL
containing	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
%	NULL
2-ME	NULL
,	NULL
60	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
and	NULL
bromphenol	NULL
blue	NULL
)	NULL
and	NULL
lysing	NULL
the	NULL
cells	NULL
by	NULL
passing	NULL
them	NULL
through	NULL
a	NULL
23G1	NULL
needle	NULL
(	NULL
three	NULL
times	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
directly	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
and	NULL
were	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Before	NULL
loading	NULL
,	NULL
samples	NULL
were	NULL
again	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
resolved	NULL
by	NULL
running	NULL
0.1	NULL
vol	NULL
on	NULL
a	NULL
SDS-12.5	NULL
%	NULL
PAGE	NULL
gel	NULL
(	NULL
acrylamide/bis-acrylamide	NULL
,	NULL
173/1	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
cellulose	NULL
nitrate	NULL
membrane	NULL
(	NULL
Schlei-cher	NULL
&	NULL
Schuell	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Immunoblotting	NULL
with	NULL
anti-ERK2	NULL
Ab	NULL
was	NULL
performed	NULL
by	NULL
standard	NULL
procedures	NULL
,	NULL
and	NULL
detection	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
guidelines	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

After	NULL
ERK2	NULL
band-shift	NULL
detection	NULL
the	NULL
membrane	NULL
was	NULL
stripped	NULL
(	NULL
strip	NULL
buffer	NULL
containing	NULL
1X	NULL
PBS	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
rehybridized	NULL
with	NULL
anti-ERK1	NULL
Ab	NULL
.	NULL

Bacterial	NULL
expression	NULL
of	NULL
GST	NULL
fusion	NULL
proteins	NULL
Bacterial	NULL
expression	NULL
of	NULL
GST-c-Jun	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
DHS5	NULL
@	NULL
,	NULL
induced	NULL
with	NULL
1	NULL
mM	NULL
isopropyl-B-p-thiogalactopyranoside	NULL
and	NULL
purified	NULL
with	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
kinase	NULL
activity	NULL
assays	NULL
for	NULL
JNK	NULL
JNK	NULL
kinase	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
enzyme	NULL
to	NULL
phosphorylate	NULL
its	NULL
substrate	NULL
proteins	NULL
c-Jun	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Before	NULL
stimulation	NULL
monocytes	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
plus	NULL
0.1	NULL
%	NULL
FBS	NULL
.	NULL

Cells	NULL
(	NULL
15	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
then	NULL
treated	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

.	NULL

After	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
resuspended	NULL
in	NULL
400	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
50	NULL
mM	NULL
B-glycerophosphate	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
10	NULL
pg/ml	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
0.4	NULL
mM	NULL
PMSF	NULL
)	NULL
and	NULL
lysed	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
3000	NULL
rpm	NULL
and	NULL
normalization	NULL
for	NULL
protein	NULL
content	NULL
in	NULL
the	NULL
superna-tant	NULL
,	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
anti-JNK	NULL
Ab	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
500	NULL
pl	NULL
and	NULL
rotated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Twenty-five	NULL
microliters	NULL
of	NULL
a	NULL
slurry	NULL
of	NULL
50	NULL
%	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
lysate/Ab	NULL
mixture	NULL
and	NULL
left	NULL
rotating	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
Ab/beads/conjugate	NULL
mixture	NULL
was	NULL
washed	NULL
with	NULL
lysis	NULL
buffer	NULL
(	NULL
three	NULL
times	NULL
)	NULL
,	NULL
twice	NULL
with	NULL
LiCl	NULL
buffer	NULL
(	NULL
500	NULL
mM	NULL
LiCl	NULL
,	NULL
100	NULL
mM	NULL
Tris-CI	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
,	NULL
and	NULL
finally	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
three	NULL
times	NULL
;	NULL
20	NULL
mM	NULL
MOPS	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

After	NULL
su-pernatant	NULL
was	NULL
completely	NULL
removed	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
50	NULL
ul	NULL
of	NULL
reaction	NULL
mix	NULL
(	NULL
43.5	NULL
gl	NULL
of	NULL
buffer	NULL
A	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
25	NULL
uM	NULL
ATP	NULL
,	NULL
3.5	NULL
mg/ml	NULL
GST-c-Jun	NULL
,	NULL
and	NULL
10	NULL
Ci	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
)	NULL
,	NULL
and	NULL
incubation	NULL
took	NULL
place	NULL
at	NULL
20°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
adding	NULL
15	NULL
ul	NULL
of	NULL
sample	NULL
buffer/2-ME	NULL
(	NULL
four	NULL
times	NULL
)	NULL
.	NULL

Before	NULL
resolving	NULL
samples	NULL
on	NULL
SDS-PAGE	NULL
gel	NULL
,	NULL
samples	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

A	NULL
m.w	NULL
.	NULL

marker	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
correct	NULL
protein	NULL
size	NULL
.	NULL

After	NULL
running	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
washed	NULL
in	NULL
water	NULL
for	NULL
15	NULL
min	NULL
,	NULL
in	NULL
5	NULL
%	NULL
TCA/1	NULL
%	NULL
sodium	NULL
pyrophosphate	NULL
(	NULL
twice	NULL
,	NULL
2	NULL
h	NULL
each	NULL
time	NULL
)	NULL
,	NULL
and	NULL
again	NULL
in	NULL
water	NULL
,	NULL
and	NULL
subsequently	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
.	NULL

Phosphorylated	NULL
substrate	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
and	NULL
was	NULL
quantified	NULL
by	NULL
densitometric	NULL
scanning	NULL
.	NULL

4895	NULL
+	NULL
3000	NULL
T	NULL
_	NULL
2500	NULL
‘	NULL
E	NULL
|	NULL
&	NULL
z	NULL
2000	NULL
|	NULL
8	NULL
man	NULL
&	NULL
8	NULL
-	NULL
7	NULL
9	NULL
i	NULL
&	NULL
1500	NULL
i	NULL
5	NULL
|	NULL
€	NULL
|	NULL
o	NULL
1	NULL
&	NULL
1000	NULL
=s	NULL
>	NULL
=	NULL
500	NULL
o	NULL
,	NULL
doua	NULL
control	NULL
OA	NULL
OA	NULL
&	NULL
anti-TNF	NULL
FIGURE	NULL
1	NULL
.	NULL

OA	NULL
induces	NULL
IL-6	NULL
secretion	NULL
from	NULL
human	NULL
monocytes	NULL
,	NULL
which	NULL
is	NULL
partly	NULL
mediated	NULL
through	NULL
TNF-	NULL
@	NULL
..	NULL
Freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°/ml	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
treatment	NULL
with	NULL
medium	NULL
,	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
OA	NULL
plus	NULL
anti-TNF-	NULL
«	NULL
,	NULL
cell-free	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
IL-6	NULL
protein	NULL
secretion	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
ELISA	NULL
kit	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
reflects	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
eight	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.005	NULL
.	NULL

Results	NULL
OA	NULL
induces	NULL
IL-6	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
Freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
serine/threonine-specific	NULL
PPase	NULL
inhibitor	NULL
OA	NULL
and	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
IL-6	NULL
protein	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
cell-free	NULL
super-natants	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

resulted	NULL
in	NULL
distinct	NULL
increases	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
IL-6	NULL
protein	NULL
(	NULL
1898	NULL
+	NULL
1164	NULL
vs	NULL
4	NULL
+	NULL
4	NULL
pg/tl	NULL
for	NULL
unstimulated	NULL
control	NULL
;	NULL
p	NULL
<	NULL
0.005	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
higher	NULL
concentrations	NULL
of	NULL
OA	NULL
,	NULL
up	NULL
to	NULL
200	NULL
ng/ml	NULL
,	NULL
induced	NULL
even	NULL
higher	NULL
levels	NULL
of	NULL
IL-6	NULL
protein	NULL
.	NULL

These	NULL
concen-trations	NULL
,	NULL
however	NULL
,	NULL
appeared	NULL
toxic	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
.	NULL

Additional	NULL
experiments	NULL
were	NULL
thus	NULL
performed	NULL
with	NULL
30	NULL
ng/ml	NULL
OA	NULL
.	NULL

OA	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
TNF-	NULL
«	NULL
from	NULL
human	NULL
monocytes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
effects	NULL
of	NULL
OA	NULL
on	NULL
IL-6	NULL
secretion	NULL
are	NULL
mediated	NULL
directly	NULL
or	NULL
indirectly	NULL
through	NULL
the	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
@	NULL
,	NULL
Ab	NULL
against	NULL
this	NULL
cytokine	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
culture	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
illustrates	NULL
that	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
OA	NULL
plus	NULL
anti-TNF-a	NULL
resulted	NULL
in	NULL
a	NULL
partial	NULL
down-regulation	NULL
of	NULL
IL-6	NULL
secretion	NULL
compared	NULL
with	NULL
that	NULL
after	NULL
treatment	NULL
with	NULL
OA	NULL
alone	NULL
(	NULL
1104	NULL
+	NULL
628	NULL
pg/ml	NULL
for	NULL
OA	NULL
plus	NULL
anti-TNF-a	NULL
vs	NULL
1898	NULL
+	NULL
1164	NULL
pg/ml	NULL
for	NULL
OA	NULL
alone	NULL
;	NULL
p	NULL
<	NULL
0.005	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
secretion	NULL
of	NULL
IL-6	NULL
protein	NULL
by	NULL
OA	NULL
is	NULL
only	NULL
partly	NULL
an	NULL
indirect	NULL
phenomenon	NULL
mediated	NULL
by	NULL
the	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
.	NULL

Addition	NULL
of	NULL
an	NULL
anti-IL-1B	NULL
Ab	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
OA-mediated	NULL
increase	NULL
in	NULL
IL-6	NULL
protein	NULL
secretion	NULL
was	NULL
established	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
nuclear	NULL
run-on	NULL
studies	NULL
were	NULL
performed	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
or	NULL
medium	NULL
plus	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
7	NULL
h	NULL
,	NULL
after	NULL
which	NULL
the	NULL
IL-6	NULL
in	NULL
vitro	NULL
transcription	NULL
rate	NULL
was	NULL
determined	NULL
.	NULL

Results	NULL
demonstrated	NULL
that	NULL
after	NULL
normalization	NULL
for	NULL
the	NULL
GAPDH	NULL
signal	NULL
,	NULL
OA	NULL
enhanced	NULL
the	NULL
IL-6	NULL
transcription	NULL
rate	NULL
3.2-fold	NULL
after	NULL
7	NULL
h	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
IL-6	NULL
transcription	NULL
rate	NULL
was	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
.	NULL

The	NULL
up-regulated	NULL
IL-6	NULL
transcription	NULL
rate	NULL
was	NULL
reflected	NULL
at	NULL
the	NULL
level	NULL
of	NULL
mRNA	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
(	NULL
0-10	NULL
h	NULL
)	NULL
resulted	NULL
in	NULL
enhanced	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-6	NULL
mRNA	NULL
was	NULL
first	NULL
observed	NULL
after	NULL
6	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
OA	NULL
.	NULL

The	NULL
slow	NULL
activation	NULL
kinetics	NULL
of	NULL
OA	NULL
,	NULL
as	NULL
observed	NULL
in	NULL
the	NULL
nuclear	NULL
run-on	NULL
and	NULL
Northern	NULL
analysis	NULL
,	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
describing	NULL
slow	NULL
activation	NULL
of	NULL
both	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
$	NULL
gene	NULL
expression	NULL
after	NULL
OA	NULL
stimulation	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4896	NULL
control	NULL
OA	NULL
pGEM	NULL
pGAPDH	NULL
_	NULL
__	NULL
pIL6	NULL
&	NULL
#	NULL
&	NULL
§	NULL
8	NULL
§	NULL
IL-6	NULL
gene	NULL
transcription	NULL
(	NULL
%	NULL
)	NULL
o	NULL
control	NULL
OA	NULL
FIGURE	NULL
2	NULL
.	NULL

OA	NULL
enhances	NULL
in	NULL
vitro	NULL
IL-6	NULL
gene	NULL
transcription	NULL
in	NULL
monocytes	NULL
.	NULL

Freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
for	NULL
16	NULL
h	NULL
and	NULL
subsequently	NULL
treated	NULL
with	NULL
medium	NULL
(	NULL
control	NULL
)	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
7	NULL
h.	NULL
Nuclei	NULL
from	NULL
40	NULL
X	NULL
10°	NULL
monocytes/group	NULL
were	NULL
isolated	NULL
and	NULL
incubated	NULL
with	NULL
[	NULL
a-*	NULL
``	NULL
P	NULL
]	NULL
JUTP	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

A	NULL
,	NULL
Radiolabeled	NULL
RNAs	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
following	NULL
cDNAs	NULL
,	NULL
which	NULL
were	NULL
immobilized	NULL
on	NULL
Hybond	NULL
N+	NULL
membranes	NULL
:	NULL
pGEM	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
,	NULL
pGAPDH	NULL
,	NULL
and	NULL
pIL6	NULL
.	NULL

Quantification	NULL
of	NULL
newly	NULL
synthesized	NULL
RNAs	NULL
was	NULL
performed	NULL
by	NULL
phosphorimaging	NULL
,	NULL
after	NULL
normalization	NULL
to	NULL
the	NULL
GAPDH	NULL
signal	NULL
.	NULL

B	NULL
,	NULL
Graphical	NULL
representation	NULL
of	NULL
the	NULL
results	NULL
obtained	NULL
after	NULL
quantification	NULL
.	NULL

OA	NULL
enhances	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
To	NULL
delineate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
in	NULL
OA-mediated	NULL
IL-6	NULL
expression	NULL
we	NULL
performed	NULL
EMSAs	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
OA-stimulated	NULL
monocytes	NULL
.	NULL

In	NULL
unstimulated	NULL
monocytes	NULL
binding	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
low	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
whereas	NULL
stimulation	NULL
with	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
for	NULL
4	NULL
or	NULL
6	NULL
h	NULL
resulted	NULL
in	NULL
a	NULL
distinct	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Exposure	NULL
to	NULL
OA	NULL
for	NULL
shorter	NULL
periods	NULL
did	NULL
not	NULL
enhance	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
performed	NULL
with	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
indicated	NULL
that	NULL
in	NULL
monocytes	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
«	NULL
B-specific	NULL
binding	NULL
sequence	NULL
,	NULL
indeed	NULL
consisted	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
,	NULL
both	NULL
before	NULL
and	NULL
after	NULL
OA	NULL
exposure	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1-3	NULL
and	NULL
4-6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
NF-KB	NULL
consisting	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
can	NULL
be	NULL
transcriptionally	NULL
active	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Two	NULL
other	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
,	NULL
c-Rel	NULL
and	NULL
p52	NULL
,	NULL
were	NULL
not	NULL
identified	NULL
in	NULL
the	NULL
OA-induced	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

OA	NULL
induces	NULL
phosphorylation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
and	NULL
activation	NULL
of	NULL
JNK1	NULL
in	NULL
monocytes	NULL
The	NULL
MAPK	NULL
signaling	NULL
cascade	NULL
involving	NULL
Raf-1	NULL
,	NULL
MEK1	NULL
,	NULL
and	NULL
ERK	NULL
1/2	NULL
phosphorylation	NULL
is	NULL
probably	NULL
an	NULL
important	NULL
signal	NULL
transduction	NULL
pathway	NULL
leading	NULL
to	NULL
cytokine	NULL
gene	NULL
expression	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effects	NULL
of	NULL
OA	NULL
on	NULL
activity	NULL
of	NULL
this	NULL
MAPK	NULL
pathway	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
phosphorylation	NULL
of	NULL
ERK1	NULL
(	NULL
p44*	NULL
``	NULL
*	NULL
)	NULL
and	NULL
ERK2	NULL
(	NULL
p42	NULL
~*	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
and	NULL
were	NULL
subsequently	NULL
analyzed	NULL
for	NULL
phosphorylated	NULL
ERK1	NULL
and	NULL
ERK2	NULL
by	NULL
means	NULL
of	NULL
immunodetection	NULL
.	NULL

As	NULL
ERK1/2	NULL
,	NULL
JNK	NULL
,	NULL
AND	NULL
c-Jun	NULL
IN	NULL
NF-	NULL
«	NULL
B-MEDIATED	NULL
IL-6	NULL
EXPRESSION	NULL
okadaic	NULL
acid	NULL
:	NULL
_	NULL
A	NULL
:	NULL
|	NULL
4	NULL
!	NULL

*	NULL
_|	NULL
*	NULL
|	NULL
*	NULL
PD98059	NULL
:	NULL
~	NULL
``	NULL
|3	NULL
``	NULL
|	NULL
-	NULL
|f	NULL
938	NULL
H7	NULL
:	NULL
s	NULL
JEOL	NULL
c	NULL
:	NULL
Lc	NULL
L	NULL
c	NULL
[	NULL
**	NULL
~~	NULL
free	NULL
oligo	NULL
e	NULL
3	NULL
-	NULL
4	NULL
5	NULL
-	NULL
6	NULL
FIGURE	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
ERK	NULL
pathway-specific	NULL
inhibitor	NULL
PD98059	NULL
and	NULL
the	NULL
serine	NULL
kinase	NULL
inhibitor	NULL
H7	NULL
on	NULL
OA-induced	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
.	NULL

An	NULL
EMSA	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NF-B	NULL
(	NULL
Zanes	NULL
1-6	NULL
)	NULL
,	NULL
was	NULL
performed	NULL
after	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
medium	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
,	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
,	NULL
4	NULL
or	NULL
6	NULL
h	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
PD98059	NULL
(	NULL
30-min	NULL
pretreatment	NULL
)	NULL
plus	NULL
OA	NULL
(	NULL
4	NULL
or	NULL
6	NULL
h	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
H7	NULL
(	NULL
30-min	NULL
pretreatment	NULL
)	NULL
plus	NULL
OA	NULL
(	NULL
4	NULL
or	NULL
6	NULL
h	NULL
;	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

A	NULL
band-shift	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
using	NULL
P-labeled	NULL
oligonucleotides	NULL
specific	NULL
for	NULL
NF-xB	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
free	NULL
probe	NULL
is	NULL
shown	NULL
.	NULL

shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
OA	NULL
induced	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
mobility	NULL
of	NULL
both	NULL
ERK1	NULL
and	NULL
ERK2	NULL
,	NULL
indicating	NULL
phosphorylation	NULL
of	NULL
the	NULL
respective	NULL
proteins	NULL
.	NULL

The	NULL
observed	NULL
shift	NULL
,	NULL
however	NULL
,	NULL
demonstrated	NULL
slow	NULL
kinetics	NULL
.	NULL

The	NULL
ERK1	NULL
shift	NULL
was	NULL
first	NULL
seen	NULL
after	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
OA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
phosphorylation	NULL
peaked	NULL
at	NULL
90	NULL
min	NULL
of	NULL
stimulation	NULL
.	NULL

The	NULL
ERK2	NULL
shift	NULL
was	NULL
first	NULL
observed	NULL
after	NULL
60	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
and	NULL
an	NULL
optimal	NULL
phosphorylation	NULL
state	NULL
was	NULL
found	NULL
at	NULL
90	NULL
min	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PMA-mediated	NULL
ERK	NULL
phosphorylation	NULL
peaked	NULL
as	NULL
early	NULL
as	NULL
5	NULL
min	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
stimulus	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
slow	NULL
activation	NULL
kinetics	NULL
of	NULL
the	NULL
ERKs	NULL
after	NULL
OA	NULL
treatment	NULL
,	NULL
we	NULL
treated	NULL
monocytes	NULL
with	NULL
OA	NULL
and	NULL
anti-TNF-	NULL
«	NULL
Ab	NULL
simultaneously	NULL
and	NULL
subsequently	NULL
analyzed	NULL
for	NULL
ERK	NULL
-	NULL
phosphorylation	NULL
.	NULL

Anti-TNF-	NULL
«	NULL
@	NULL
coincubation	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
OA-induced	NULL
ERK	NULL
shifts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
delayed	NULL
onset	NULL
of	NULL
OA-induced	NULL
activity	NULL
was	NULL
described	NULL
previously	NULL
for	NULL
OA-mediated	NULL
ERK	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
lymphocytes	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

A	NULL
relevant	NULL
explanation	NULL
for	NULL
the	NULL
delayed	NULL
onset	NULL
is	NULL
that	NULL
OA	NULL
elicits	NULL
its	NULL
effect	NULL
by	NULL
disrupting	NULL
the	NULL
balance	NULL
between	NULL
low	NULL
,	NULL
basal	NULL
protein	NULL
phosphorylation	NULL
and	NULL
basal	NULL
protein	NULL
de-phosphorylation	NULL
in	NULL
favor	NULL
of	NULL
protein	NULL
phosphorylation	NULL
.	NULL

Signaling	NULL
modules	NULL
will	NULL
be	NULL
subsequently	NULL
activated	NULL
only	NULL
after	NULL
a	NULL
relatively	NULL
long	NULL
incubation	NULL
time	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
PD98059	NULL
+	NULL
control	NULL
okadaic	NULL
acid	NULL
okadaic	NULL
acid	NULL
antibody	NULL
:	NULL
_	NULL
-	NULL
_	NULL
p65	NULL
p50	NULL
-	NULL
_	NULL
p65	NULL
.	NULL

p50	NULL
-	NULL
-	NULL
péS	NULL
p50	NULL
p65	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6°	NULL
7	NULL
8	NULL
9	NULL
FIGURE	NULL
4	NULL
.	NULL

OA	NULL
treatment	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
composition	NULL
of	NULL
NF-KB	NULL
.	NULL

A	NULL
,	NULL
Supershift	NULL
experiments	NULL
with	NULL
an	NULL
Ab	NULL
against	NULL
the	NULL
p65	NULL
and	NULL
pSO	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMSAs	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
after	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
medium	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
,	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
,	NULL
6	NULL
h	NULL
;	NULL
lanes	NULL
4-6	NULL
)	NULL
,	NULL
or	NULL
PD98059	NULL
(	NULL
30-min	NULL
pretreatment	NULL
)	NULL
plus	NULL
OA	NULL
(	NULL
6	NULL
h	NULL
;	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
oligonucleotide	NULL
and	NULL
polyclonal	NULL
Ab	NULL
against	NULL
the	NULL
p50	NULL
or	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

B	NULL
,	NULL
Shorter	NULL
exposure	NULL
of	NULL
same	NULL
EMSA	NULL
to	NULL
demonstrate	NULL
enhanced	NULL
DNA	NULL
binding	NULL
activity	NULL
due	NULL
to	NULL
OA	NULL
treatment	NULL
and	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
PD98059	NULL
pretreatment	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
JNKs	NULL
are	NULL
,	NULL
like	NULL
the	NULL
ERKs	NULL
,	NULL
members	NULL
of	NULL
the	NULL
MAPK	NULL
family	NULL
and	NULL
are	NULL
also	NULL
known	NULL
as	NULL
SAPK	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

We	NULL
determined	NULL
activation	NULL
of	NULL
the	NULL
JNK	NULL
pathway	NULL
by	NULL
measuring	NULL
JNK	NULL
in	NULL
vitro	NULL
kinase	NULL
activity	NULL
as	NULL
a	NULL
result	NULL
of	NULL
OA	NULL
treatment	NULL
.	NULL

After	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
JNK	NULL
1	NULL
was	NULL
immunoprecipi-tated	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
subsequently	NULL
assayed	NULL
for	NULL
in	NULL
vitro	NULL
kinase	NULL
activity	NULL
toward	NULL
its	NULL
specific	NULL
substrate	NULL
(	NULL
c-Jun	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
radiolabeled	NULL
ATP	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
OA	NULL
enhanced	NULL
JNK1	NULL
activity	NULL
as	NULL
early	NULL
as	NULL
15	NULL
min	NULL
after	NULL
stimulation	NULL
.	NULL

JNK1	NULL
kinase	NULL
activity	NULL
peaked	NULL
at	NULL
90	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
OA	NULL
.	NULL

4897	NULL
control	NULL
OA	NULL
2	NULL
%	NULL
f	NULL
g	NULL
antibody	NULL
:	NULL
1	NULL
60	NULL
A-	NULL
&	NULL
40	NULL
a	NULL
NF-	NULL
«	NULL
B	NULL
-+	NULL
rsf	NULL
IF	NULL
T	NULL
free	NULL
oligo	NULL
FIGURE	NULL
5.	NULL
c-Rel	NULL
and	NULL
p52	NULL
are	NULL
not	NULL
present	NULL
in	NULL
OA-induced	NULL
NF-B	NULL
complex	NULL
.	NULL

EMSAs	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
after	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
medium	NULL
and	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
(	NULL
3	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
oligonucleotide	NULL
and	NULL
polyclonal	NULL
Ab	NULL
against	NULL
the	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
p52	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Supershift	NULL
experiments	NULL
with	NULL
the	NULL
Abs	NULL
against	NULL
the	NULL
c-Rel	NULL
and	NULL
p52	NULL
NF-KB	NULL
family	NULL
members	NULL
clearly	NULL
demonstrate	NULL
the	NULL
absence	NULL
of	NULL
these	NULL
subunits	NULL
in	NULL
the	NULL
OA-induced	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
complex	NULL
.	NULL

p50	NULL
and	NULL
p65	NULL
are	NULL
present	NULL
in	NULL
the	NULL
complex	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
considerable	NULL
decrease	NULL
in	NULL
DNA-bound	NULL
NF-KB	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
low	NULL
amount	NULL
of	NULL
protein	NULL
,	NULL
supershifts	NULL
are	NULL
not	NULL
readily	NULL
detectable	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
ERK	NULL
pathway	NULL
by	NULL
PD98059	NULL
down-regulates	NULL
OA-mediated	NULL
IL-6	NULL
secretion	NULL
,	NULL
but	NULL
not	NULL
NF-	NULL
«	NULL
xB	NULL
DNA	NULL
binding	NULL
activity	NULL
To	NULL
summarize	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
OA	NULL
up-regulated	NULL
IL-6	NULL
protein	NULL
and	NULL
mRNA	NULL
levels	NULL
in	NULL
monocytes	NULL
,	NULL
which	NULL
coincided	NULL
with	NULL
enhanced	NULL
OA	NULL
PMA	NULL
time	NULL
(	NULL
min	NULL
)	NULL
0°	NULL
5°	NULL
15	NULL
!	NULL

60°	NULL
90°	NULL
5	NULL
ERK1	NULL
<	NULL
FIGURE	NULL
6	NULL
.	NULL

OA	NULL
induces	NULL
phosphorylation	NULL
of	NULL
ERK1	NULL
(	NULL
p44*	NULL
``	NULL
*	NULL
)	NULL
and	NULL
ERK2	NULL
(	NULL
p42*	NULL
``	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
monocytes	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
FBS	NULL
and	NULL
were	NULL
subsequently	NULL
stimulated	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
periods	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
for	NULL
5	NULL
min	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Phosphorylated	NULL
ERK	NULL
1	NULL
and	NULL
ERK2	NULL
are	NULL
marked	NULL
by	NULL
the	NULL
arrows	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoblotting	NULL
with	NULL
anti-ERK2	NULL
Ab	NULL
was	NULL
performed	NULL
by	NULL
standard	NULL
procedures	NULL
,	NULL
and	NULL
detection	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
ECL	NULL
immunodetection	NULL
kit	NULL
.	NULL

After	NULL
ERK2	NULL
band-shift	NULL
detection	NULL
the	NULL
membrane	NULL
was	NULL
stripped	NULL
(	NULL
strip	NULL
buffer	NULL
containing	NULL
1	NULL
X	NULL
PBS	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
rehybridized	NULL
with	NULL
the	NULL
anti-ERK1	NULL
Ab	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4898	NULL
OA	NULL
anisomycin	NULL
time	NULL
(	NULL
min	NULL
)	NULL
Q	NULL
15°	NULL
30°	NULL
90	NULL
3T	NULL
JNK	NULL
sane	NULL
-	NULL
With	NULL
CW	NULL
--	NULL
FIGURE	NULL
7	NULL
.	NULL

OA	NULL
induces	NULL
JNK	NULL
kinase	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Before	NULL
stimulation	NULL
monocytes	NULL
were	NULL
cultured	NULL
for	NULL
16	NULL
h	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
0.1	NULL
%	NULL
FBS	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
treated	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

Anisomycin	NULL
stimulation	NULL
for	NULL
5	NULL
min	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
JNK	NULL
from	NULL
cell	NULL
lysates	NULL
is	NULL
described	NULL
in	NULL
detail	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Kinase	NULL
reaction	NULL
with	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
was	NULL
initiated	NULL
by	NULL
adding	NULL
50	NULL
pl	NULL
of	NULL
reaction	NULL
mix	NULL
(	NULL
containing	NULL
GST-c-Jun	NULL
for	NULL
JNK	NULL
kinase	NULL
assay	NULL
)	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
took	NULL
place	NULL
at	NULL
20°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
termination	NULL
of	NULL
the	NULL
reaction	NULL
and	NULL
boiling	NULL
the	NULL
samples	NULL
for	NULL
5	NULL
min	NULL
,	NULL
samples	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
gel	NULL
.	NULL

Phosphorylated	NULL
substrate	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
,	NULL
and	NULL
a	NULL
m.w	NULL
.	NULL

marker	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
correct	NULL
protein	NULL
size	NULL
.	NULL

binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
MAP	NULL
kinases	NULL
ERK	NULL
1	NULL
,	NULL
ERK2	NULL
,	NULL
and	NULL
JNK	NULL
1	NULL
were	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
OA	NULL
treatment	NULL
.	NULL

The	NULL
question	NULL
remains	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
the	NULL
OA-induced	NULL
phosphorylation	NULL
of	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
and	NULL
JNK1	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
by	NULL
OA	NULL
.	NULL

To	NULL
answer	NULL
this	NULL
question	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
ERK	NULL
1/2	NULL
pathway	NULL
we	NULL
treated	NULL
monocytes	NULL
with	NULL
the	NULL
Raf-1/MEKI1/ERK	NULL
pathway-specific	NULL
pharmacological	NULL
inhibitor	NULL
PD98059	NULL
.	NULL

At	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
wM	NULL
PD98059	NULL
the	NULL
activity	NULL
of	NULL
MEK	NULL
1	NULL
,	NULL
the	NULL
kinase	NULL
upstream	NULL
from	NULL
ERK1	NULL
and	NULL
ERK2	NULL
,	NULL
was	NULL
almost	NULL
totally	NULL
inhibited	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
PD98059	NULL
dramatically	NULL
down-regulates	NULL
OA-induced	NULL
IL-6	NULL
secretion	NULL
(	NULL
100	NULL
%	NULL
for	NULL
OA-induced	NULL
IL-6	NULL
secretion	NULL
vs	NULL
7.3	NULL
+	NULL
4.1	NULL
%	NULL
for	NULL
PD98059-	NULL
plus	NULL
OA-mediated	NULL
IL-6	NULL
secretion	NULL
;	NULL
p	NULL
<	NULL
0.005	NULL
;	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
OA-enhanced	NULL
phosphorylation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
is	NULL
an	NULL
important	NULL
step	NULL
in	NULL
the	NULL
elevation	NULL
of	NULL
IL-6	NULL
protein	NULL
levels	NULL
.	NULL

PD98059	NULL
at	NULL
this	NULL
concentration	NULL
was	NULL
not	NULL
toxic	NULL
for	NULL
the	NULL
monocytes	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
assays	NULL
and	NULL
lactate	NULL
dehydrogenase	NULL
levels	NULL
in	NULL
culture	NULL
supernatants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Band-shift	NULL
assays	NULL
using	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
monocytes	NULL
pretreated	NULL
with	NULL
PD98059	NULL
for	NULL
30	NULL
min	NULL
before	NULL
OA	NULL
stimulation	NULL
for	NULL
6	NULL
h	NULL
demonstrated	NULL
no	NULL
considerable	NULL
change	NULL
in	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
or	NULL
of	NULL
AP-1	NULL
or	NULL
NF-IL6	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
deter	NULL
100	NULL
€	NULL
so	NULL
£	NULL
E	NULL
so	NULL
5	NULL
40	NULL
20	NULL
*	NULL
T	NULL
o	NULL
,	NULL
|_I—\	NULL
Alls	NULL
OA	NULL
PD	NULL
&	NULL
OA	NULL
117	NULL
&	NULL
OA	NULL
FIGURE	NULL
8	NULL
.	NULL

OA-induced	NULL
IL-6	NULL
secretion	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
ERK	NULL
path	NULL
way-specific	NULL
inhibitor	NULL
PD98059	NULL
and	NULL
the	NULL
serine	NULL
kinase	NULL
inhibitor	NULL
H7	NULL
.	NULL

Freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
%	NULL
/ml	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
%	NULL
FBS	NULL
as	NULL
described	NULL
under	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Sixteen	NULL
hours	NULL
after	NULL
adherence	NULL
cells	NULL
were	NULL
stimulated	NULL
as	NULL
follows	NULL
:	NULL
medium	NULL
,	NULL
OA	NULL
(	NULL
30	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
30-min	NULL
pretreatment	NULL
with	NULL
either	NULL
PD98059	NULL
or	NULL
H7	NULL
followed	NULL
by	NULL
OA	NULL
stimulation	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
treatment	NULL
cell-free	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
IL-6	NULL
protein	NULL
secretion	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
ELISA	NULL
kit	NULL
.	NULL

Both	NULL
reflect	NULL
the	NULL
average	NULL
+	NULL
SD	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.005	NULL
.	NULL

ERK1/2	NULL
,	NULL
JNK	NULL
,	NULL
AND	NULL
c-Jun	NULL
IN	NULL
NF-	NULL
«	NULL
B-MEDIATED	NULL
IL-6	NULL
EXPRESSION	NULL
mined	NULL
after	NULL
phosphorimaging	NULL
quantification	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Zanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
ERK	NULL
pathway	NULL
did	NULL
not	NULL
play	NULL
a	NULL
role	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

We	NULL
,	NULL
subsequently	NULL
,	NULL
demonstrated	NULL
that	NULL
the	NULL
observed	NULL
difference	NULL
between	NULL
inhibited	NULL
IL-6	NULL
protein	NULL
secretion	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
effect	NULL
regarding	NULL
NF-KB	NULL
binding	NULL
activity	NULL
by	NULL
PD98059	NULL
could	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
change	NULL
in	NULL
composition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
consisted	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
both	NULL
with	NULL
and	NULL
without	NULL
PD98059	NULL
pretreatment	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
4-9	NULL
)	NULL
.	NULL

OA	NULL
enhances	NULL
IL-6	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
TF-1	NULL
myeloid	NULL
cell	NULL
line	NULL
IL-6	NULL
transcription	NULL
was	NULL
investigated	NULL
in	NULL
more	NULL
detail	NULL
by	NULL
transiently	NULL
transfecting	NULL
the	NULL
TF-1	NULL
cell	NULL
line	NULL
with	NULL
three	NULL
5'-end	NULL
deletion	NULL
constructs	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
IL-6	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
plL6luc	NULL
(	NULL
-602	NULL
)	NULL
,	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
,	NULL
and	NULL
pIL6luc	NULL
(	NULL
-60	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

Results	NULL
from	NULL
the	NULL
transfection	NULL
experiments	NULL
demonstrated	NULL
that	NULL
,	NULL
in	NULL
concordance	NULL
with	NULL
the	NULL
observations	NULL
in	NULL
monocytes	NULL
,	NULL
OA	NULL
induced	NULL
activity	NULL
of	NULL
the	NULL
entire	NULL
IL-6	NULL
promoter	NULL
in	NULL
TF-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

After	NULL
-	NULL
transfection	NULL
-	NULL
with	NULL
the	NULL
largest	NULL
promoter	NULL
construct	NULL
plLéluc	NULL
(	NULL
-602	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
AP-1	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
up-regulated	NULL
IL-6	NULL
promoter	NULL
activity	NULL
7.8	NULL
+	NULL
4.8-fold	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

When	NULL
plLéluc	NULL
(	NULL
-112	NULL
)	NULL
,	NULL
which	NULL
merely	NULL
contains	NULL
the	NULL
NF-KB	NULL
binding	NULL
site	NULL
,	NULL
was	NULL
introduced	NULL
into	NULL
TF-1	NULL
cells	NULL
,	NULL
OA	NULL
elicited	NULL
a	NULL
14.3	NULL
+	NULL
10.0-fold	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
induction	NULL
in	NULL
IL-6	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
would	NULL
imply	NULL
possible	NULL
negative	NULL
regulatory	NULL
cis	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
downstream	NULL
from	NULL
the	NULL
NF-KB	NULL
site	NULL
,	NULL
within	NULL
the	NULL
region	NULL
-122	NULL
through	NULL
-602	NULL
.	NULL

Using	NULL
a	NULL
promoter	NULL
construct	NULL
lacking	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
any	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
(	NULL
pIL6luc	NULL
(	NULL
-60	NULL
)	NULL
)	NULL
,	NULL
a	NULL
minimal	NULL
residual	NULL
induction	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
after	NULL
OA	NULL
treatment	NULL
(	NULL
1.5	NULL
+	NULL
0.3-fold	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
OA	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
IL-6	NULL
gene	NULL
transcription	NULL
,	NULL
and	NULL
furthermore	NULL
,	NULL
that	NULL
transactivation	NULL
by	NULL
the	NULL
NF-KB	NULL
complex	NULL
greatly	NULL
contributes	NULL
to	NULL
OA-induced	NULL
IL-6	NULL
gene	NULL
transcription	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
OA	NULL
can	NULL
indeed	NULL
directly	NULL
enhance	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
TF-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
pGAL4-p65	NULL
or	NULL
pGAL4-dbd	NULL
constructs	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
pGALAtklue	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
GAL4-transactivator	NULL
fusion	NULL
proteins	NULL
are	NULL
exclusively	NULL
nuclear	NULL
and	NULL
are	NULL
regulated	NULL
independently	NULL
of	NULL
IB	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
pGALAtklue	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
multiple	NULL
GALA	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
GAL4	NULL
one-hybrid	NULL
technique	NULL
allows	NULL
analysis	NULL
of	NULL
the	NULL
«	NULL
B	NULL
p65	NULL
transactivation	NULL
mechanism	NULL
.	NULL

The	NULL
results	NULL
demonstrated	NULL
that	NULL
OA	NULL
enhanced	NULL
p65-mediated	NULL
transactivation	NULL
by	NULL
2.2	NULL
+	NULL
1.2-fold	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
OA	NULL
on	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
.	NULL

Transfection	NULL
with	NULL
the	NULL
negative	NULL
control	NULL
plasmid	NULL
pGAL4-dbd	NULL
showed	NULL
no	NULL
enhanced	NULL
promoter	NULL
activity	NULL
after	NULL
OA	NULL
treatment	NULL
.	NULL

Inactive	NULL
mutants	NULL
of	NULL
Raf-1	NULL
and	NULL
JNK1	NULL
down-regulate	NULL
NFkB-mediated	NULL
promoter	NULL
activity	NULL
Since	NULL
previous	NULL
reports	NULL
on	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
have	NULL
emphasized	NULL
the	NULL
indispensability	NULL
of	NULL
the	NULL
NF-KB	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
,	NULL
we	NULL
focussed	NULL
on	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
ERK1/2	NULL
and	NULL
JNK1	NULL
pathways	NULL
in	NULL
NF-	NULL
«	NULL
B-depen-dent	NULL
IL-6	NULL
promoter	NULL
activity	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
TE-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
pIL6luc	NULL
(	NULL
-122	NULL
)	NULL
,	NULL
comprising	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
only	NULL
,	NULL
together	NULL
with	NULL
either	NULL
pRSV-NARaf1	NULL
or	NULL
peDNA3-Flag-JNK1	NULL
,	NULL
before	NULL
stimulation	NULL
with	NULL
OA	NULL
.	NULL

Previously	NULL
,	NULL
pRSV-NARafl	NULL
,	NULL
encoding	NULL
a	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
Raf-1	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
block	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activity	NULL
by	NULL
growth	NULL
factors	NULL
(	NULL
35	NULL
)	NULL
.	NULL

pcDNA3-Flag-JINK1	NULL
encodes	NULL
a	NULL
catalytically	NULL
inactive	NULL
mutant	NULL
of	NULL
JNK	NULL
1	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

104	NULL
.	NULL

Both	NULL
pRSV-NARafi	NULL
(	NULL
10	NULL
+	NULL
8	NULL
%	NULL
for	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
NF-IL6	NULL
-	NULL
NF-xB	NULL
-158/145	NULL
-137-63	NULL
H	NULL
~_	NULL
]	NULL
)	NULL
-	NULL
luciferase	NULL
=	NULL
AP-1	NULL
83277	NULL
plLéluc	NULL
(	NULL
-602	NULL
)	NULL
__	NULL
]	NULL
plL6luc	NULL
(	NULL
-122	NULL
)	NULL
plL6luc	NULL
(	NULL
-60	NULL
)	NULL
luciferase	NULL
B	NULL
25	NULL
if	NULL
z	NULL
20	NULL
i	NULL
3	NULL
|	NULL
3	NULL
:	NULL
e	NULL
|	NULL
5	NULL
15	NULL
I	NULL
€	NULL
*	NULL
B	NULL
[	NULL
£	NULL
10	NULL
|	NULL
3	NULL
9	NULL
2	NULL
5	NULL
<	NULL
5	NULL
3	NULL
3	NULL
o	NULL
L	NULL
C-	NULL
C1	NULL
I	NULL
control	NULL
OA	NULL
control	NULL
OA	NULL
control	NULL
OA	NULL
plL6luc	NULL
(	NULL
-602	NULL
)	NULL
pll6lue	NULL
(	NULL
-122	NULL
)	NULL
C	NULL
4	NULL
Be	NULL
|	NULL
9	NULL
!	NULL

Bl	NULL
:	NULL
B	NULL
3	NULL
e	NULL
T2	NULL
2	NULL
£	NULL
§	NULL
2	NULL
E	NULL
1	NULL
an	NULL
&	NULL
3	NULL
.	NULL

0	NULL
control	NULL
OA	NULL
control	NULL
OA	NULL
pGAL4p65	NULL
pGAL4dbd	NULL
FIGURE	NULL
9	NULL
.	NULL

OA	NULL
enhances	NULL
IL-6	NULL
promoter	NULL
activity	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
three	NULL
IL-6	NULL
promoter	NULL
constructs	NULL
applied	NULL
in	NULL
the	NULL
transfections	NULL
of	NULL
TF-1	NULL
cell	NULL
line	NULL
.	NULL

Various	NULL
portions	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
are	NULL
fused	NULL
to	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

Binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
,	NULL
NF-IL6	NULL
,	NULL
and	NULL
NF-KB	NULL
are	NULL
denoted	NULL
above	NULL
the	NULL
largest	NULL
construct	NULL
.	NULL

B	NULL
,	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
transiently	NULL
transfected	NULL
TP-1	NULL
cells	NULL
.	NULL

TF-1	NULL
cells	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
subsequently	NULL
transiently	NULL
transfected	NULL
by	NULL
means	NULL
of	NULL
electroporation	NULL
with	NULL
25	NULL
ug	NULL
of	NULL
the	NULL
respective	NULL
plasmids	NULL
.	NULL

Six	NULL
hours	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
stimulation	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
luciferase	NULL
protein	NULL
produced	NULL
.	NULL

The	NULL
IL-6	NULL
promoter	NULL
activity	NULL
for	NULL
each	NULL
construct	NULL
when	NULL
treated	NULL
with	NULL
medium	NULL
only	NULL
is	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
SD	NULL
represent	NULL
three	NULL
or	NULL
more	NULL
identical	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
.	NULL

C	NULL
,	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
GAL4-p65	NULL
frans-activational	NULL
activity	NULL
in	NULL
the	NULL
transiently	NULL
transfected	NULL
TF-1	NULL
cells	NULL
.	NULL

TF-1	NULL
cells	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
subsequently	NULL
transiently	NULL
transfected	NULL
by	NULL
means	NULL
of	NULL
electroporation	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
reporter	NULL
pGALAtkluc	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pGAL4-p65	NULL
expression	NULL
vector	NULL
.	NULL

Six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
produced	NULL
luciferase	NULL
protein	NULL
.	NULL

Basal	NULL
p65	NULL
transcriptional	NULL
activity	NULL
is	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
SD	NULL
shown	NULL
represent	NULL
six	NULL
identical	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
.	NULL

4899	NULL
A	NULL
|pLéluc	NULL
(	NULL
-122	NULL
)	NULL
100	NULL
*	NULL
--	NULL
80	NULL
g	NULL
E	NULL
i	NULL
s	NULL
60	NULL
&	NULL
9	NULL
&	NULL
E	NULL
40	NULL
'	NULL
o	NULL
3	NULL
20	NULL
*	NULL
.	NULL

(	NULL
*	NULL
o	NULL
1	NULL
E	NULL
>	NULL
£	NULL
C	NULL
--	NULL
]	NULL
peDNA3	NULL
don	NULL
.	NULL

raf-1	NULL
dn	NULL
.	NULL

JNKL	NULL
TAM67	NULL
B	NULL
|	NULL
pNFkB3xCAT	NULL
100	NULL
*	NULL
80	NULL
*	NULL
T	NULL
€	NULL
T	NULL
|	NULL
z	NULL
.	NULL

60	NULL
|	NULL
E	NULL
=	NULL
3	NULL
E	NULL
*	NULL
a	NULL
40	NULL
*	NULL
O	NULL
20	NULL
o	NULL
i	NULL
peDNA3	NULL
d.n	NULL
.	NULL

raf-1	NULL
don	NULL
.	NULL

JNKT	NULL
TAMG7	NULL
FIGURE	NULL
10	NULL
.	NULL

Dominant	NULL
negative	NULL
mutants	NULL
of	NULL
Raf-1	NULL
,	NULL
JNK1	NULL
,	NULL
and	NULL
c-Jun	NULL
inhibit	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

A	NULL
,	NULL
TF-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
plL6luc	NULL
(	NULL
-122	NULL
)	NULL
together	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
1	NULL
)	NULL
peDNA3	NULL
empty	NULL
vector	NULL
,	NULL
2	NULL
)	NULL
pRSV-NAraf1	NULL
,	NULL
3	NULL
)	NULL
pcDNA3-Flag-JNK1	NULL
,	NULL
or	NULL
4	NULL
)	NULL
pCMV-TAM67	NULL
.	NULL

Six	NULL
hours	NULL
after	NULL
electroporation	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
medium	NULL
or	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
stimulation	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
luciferase	NULL
protein	NULL
produced	NULL
.	NULL

The	NULL
IL-6	NULL
promoter	NULL
activity	NULL
for	NULL
the	NULL
peDNA3	NULL
construct	NULL
when	NULL
treated	NULL
with	NULL
OA	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
SD	NULL
shown	NULL
represent	NULL
at	NULL
least	NULL
three	NULL
identical	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
.	NULL

B	NULL
,	NULL
Same	NULL
as	NULL
described	NULL
in	NULL
A	NULL
,	NULL
but	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
3xCAT	NULL
instead	NULL
of	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05.	NULL
pRSV-NARaf1	NULL
vs	NULL
100	NULL
%	NULL
for	NULL
peDNA3	NULL
;	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
and	NULL
peDNA¥3-Flag-JNK1	NULL
(	NULL
54	NULL
+	NULL
32	NULL
%	NULL
for	NULL
peDNA3-Flag-JNK1	NULL
vs	NULL
100	NULL
%	NULL
for	NULL
peDNA3	NULL
;	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
inhibited	NULL
NF-	NULL
«	NULL
B-mediated	NULL
IL-6	NULL
promoter	NULL
activity	NULL
.	NULL

Moreover	NULL
,	NULL
cotransfections	NULL
of	NULL
the	NULL
pCMVlue	NULL
plasmid	NULL
,	NULL
containing	NULL
a	NULL
constitutive	NULL
promoter	NULL
,	NULL
with	NULL
either	NULL
pRSV-NArafl	NULL
or	NULL
peDNA3-Flag-JNK1	NULL
did	NULL
not	NULL
affect	NULL
constitutive	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
observations	NULL
emphasize	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
MAP	NULL
kinase	NULL
constructs	NULL
in	NULL
inhibiting	NULL
IL-6	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
findings	NULL
were	NULL
indeed	NULL
correlated	NULL
with	NULL
the	NULL
transactivation	NULL
capacity	NULL
of	NULL
NF-B	NULL
itself	NULL
and	NULL
not	NULL
with	NULL
possible	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
,	NULL
TF-1	NULL
cells	NULL
were	NULL
simultaneously	NULL
transfected	NULL
with	NULL
pRSV-NARafl	NULL
or	NULL
peDNA3-Flag-JNK1	NULL
and	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
3xCAT	NULL
.	NULL

This	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
solely	NULL
contains	NULL
three	NULL
consecutive	NULL
GGGAAAATCC	NULL
kB	NULL
binding	NULL
sites	NULL
adjacent	NULL
to	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL

Again	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
both	NULL
pRSV-NARafl	NULL
and	NULL
peDNA3-Flag-JNK1	NULL
impaired	NULL
OA-induced	NULL
«	NULL
B-mediated	NULL
gene	NULL
transcription	NULL
(	NULL
58	NULL
+	NULL
11	NULL
%	NULL
for	NULL
pRSV-NARaf1	NULL
vs	NULL
100	NULL
%	NULL
for	NULL
peDNA3	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
and	NULL
54	NULL
+	NULL
24	NULL
%	NULL
for	NULL
peDNA3-Flag-JNK1	NULL
vs	NULL
100	NULL
%	NULL
for	NULL
peDNA3	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
;	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
would	NULL
implicate	NULL
a	NULL
role	NULL
for	NULL
both	NULL
the	NULL
Raf-1/MEK1/ERK	NULL
and	NULL
the	NULL
MEKK1/JNK	NULL
pathways	NULL
in	NULL
enhancing	NULL
the	NULL
NF-KB	NULL
transactivation	NULL
capacity	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4900	NULL
plléluc	NULL
(	NULL
-122	NULL
)	NULL
2000	NULL
T	NULL
i	NULL
1500	NULL
1	NULL
>	NULL
2	NULL
od	NULL
&	NULL
Fa	NULL
i	NULL
4	NULL
500	NULL
o	NULL
1	NULL
<	NULL
_	NULL
control	NULL
OA	NULL
H7	NULL
[	NULL
17	NULL
&	NULL
OA	NULL
FIGURE	NULL
11	NULL
.	NULL

Serine	NULL
kinase	NULL
inhibitor	NULL
H7	NULL
down-regulates	NULL
NF-	NULL
«	NULL
B-medi-	NULL
ated	NULL
IL-6	NULL
promoter	NULL
activity	NULL
.	NULL

TF-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
with	NULL
25	NULL
pug	NULL
of	NULL
pIL6luc	NULL
(	NULL
-122	NULL
)	NULL
.	NULL

Six	NULL
hours	NULL
after	NULL
electroporation	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
medium	NULL
,	NULL
OA	NULL
(	NULL
30	NULL
ng/ml	NULL
)	NULL
,	NULL
H7	NULL
,	NULL
or	NULL
H7	NULL
plus	NULL
OA	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
stimulation	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
luciferase	NULL
protein	NULL
produced	NULL
.	NULL

The	NULL
IL-6	NULL
promoter	NULL
activity	NULL
for	NULL
cells	NULL
treated	NULL
with	NULL
medium	NULL
was	NULL
set	NULL
at	NULL
100	NULL
%	NULL
.	NULL

This	NULL
figure	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
identical	NULL
,	NULL
independent	NULL
experiments	NULL
.	NULL

NF-	NULL
«	NULL
xB-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
,	NULL
but	NULL
not	NULL
NF-	NULL
«	NULL
xB	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
is	NULL
serine	NULL
kinase	NULL
dependent	NULL
With	NULL
the	NULL
described	NULL
results	NULL
we	NULL
demonstrated	NULL
that	NULL
both	NULL
the	NULL
MEKK1/	NULL
JNK	NULL
and	NULL
Raf-1/MEK1/ERK	NULL
pathways	NULL
are	NULL
involved	NULL
in	NULL
enhancing	NULL
NF-	NULL
«	NULL
B-mediated	NULL
promoter	NULL
activity	NULL
,	NULL
but	NULL
the	NULL
latter	NULL
pathway	NULL
does	NULL
not	NULL
affect	NULL
OA-induced	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
.	NULL

This	NULL
observed	NULL
difference	NULL
would	NULL
imply	NULL
an	NULL
activation	NULL
signal	NULL
different	NULL
from	NULL
mere	NULL
binding	NULL
of	NULL
NF-KB	NULL
to	NULL
its	NULL
consensus	NULL
sequence	NULL
.	NULL

To	NULL
resolve	NULL
whether	NULL
serine	NULL
kinase	NULL
activity	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
this	NULL
process	NULL
,	NULL
transiently	NULL
transfected	NULL
TF-1	NULL
cells	NULL
with	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
serine	NULL
ki-nase-specific	NULL
inhibitor	NULL
H7	NULL
30	NULL
min	NULL
before	NULL
OA	NULL
stimulation	NULL
.	NULL

Fig	NULL
.	NULL

11	NULL
is	NULL
a	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

H7	NULL
was	NULL
capable	NULL
of	NULL
reducing	NULL
basal	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
promoter	NULL
activity	NULL
.	NULL

More	NULL
im-portantly	NULL
,	NULL
however	NULL
,	NULL
OA-induced	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
promoter	NULL
activity	NULL
was	NULL
blocked	NULL
10-	NULL
to	NULL
100-fold	NULL
by	NULL
H7	NULL
,	NULL
which	NULL
coincided	NULL
with	NULL
dramatically	NULL
reduced	NULL
IL-6	NULL
protein	NULL
secretion	NULL
levels	NULL
in	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
band-shift	NULL
assays	NULL
demonstrated	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
NF-KB	NULL
to	NULL
its	NULL
consensus	NULL
sequence	NULL
was	NULL
not	NULL
altered	NULL
due	NULL
to	NULL
H7	NULL
pre-treatment	NULL
,	NULL
implying	NULL
an	NULL
essential	NULL
role	NULL
for	NULL
serine	NULL
kinase	NULL
activity	NULL
in	NULL
regulating	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

H7	NULL
pretreatment	NULL
did	NULL
inhibit	NULL
AP-1	NULL
binding	NULL
activity	NULL
,	NULL
indicating	NULL
differential	NULL
signaling	NULL
modules	NULL
involved	NULL
in	NULL
binding	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TAM67	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
c-Jun	NULL
,	NULL
inhibits	NULL
NF-	NULL
«	NULL
xB-mediated	NULL
IL-6	NULL
promoter	NULL
activity	NULL
Recent	NULL
work	NULL
has	NULL
indicated	NULL
that	NULL
Rel	NULL
family	NULL
members	NULL
may	NULL
interact	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
to	NULL
elicit	NULL
transactivation	NULL
of	NULL
genes	NULL
.	NULL

One	NULL
such	NULL
example	NULL
is	NULL
the	NULL
AP-1	NULL
complex	NULL
(	NULL
8	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Since	NULL
blocking	NULL
the	NULL
JNK	NULL
pathway	NULL
inhibited	NULL
transactivation	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
c-Jun	NULL
,	NULL
an	NULL
important	NULL
downstream	NULL
target	NULL
of	NULL
JNK1	NULL
,	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
transfected	NULL
TF-1	NULL
cells	NULL
with	NULL
the	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
construct	NULL
together	NULL
with	NULL
pCMV-TAM67	NULL
,	NULL
the	NULL
N-terminally	NULL
truncated	NULL
dominant	NULL
negative	NULL
c-Jun	NULL
expression	NULL
vector	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
effectivity	NULL
of	NULL
pCMV-TAM67	NULL
was	NULL
verified	NULL
using	NULL
a	NULL
reporter	NULL
containing	NULL
five	NULL
consecutive	NULL
AP-1	NULL
binding	NULL
sites	NULL
(	NULL
p	NULL
(	NULL
TRE	NULL
)	NULL
S5xCAT	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
composed	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
subunits	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
confirmed	NULL
that	NULL
reporter	NULL
activity	NULL
was	NULL
indeed	NULL
inhibited	NULL
when	NULL
p	NULL
(	NULL
TRE	NULL
)	NULL
SxCAT	NULL
was	NULL
ERK1/2	NULL
,	NULL
JNK	NULL
,	NULL
AND	NULL
c-Jun	NULL
IN	NULL
NF-	NULL
«	NULL
B-MEDIATED	NULL
IL-6	NULL
EXPRESSION	NULL
cotransfected	NULL
with	NULL
pCMV-TAM67	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

OA-induced	NULL
NF-	NULL
«	NULL
B-driven	NULL
IL-6	NULL
promoter	NULL
activity	NULL
was	NULL
dramatically	NULL
down-modulated	NULL
after	NULL
introduction	NULL
of	NULL
pCMV-TAM67	NULL
(	NULL
100	NULL
%	NULL
and	NULL
5.9	NULL
+	NULL
0.5	NULL
%	NULL
;	NULL
p	NULL
<	NULL
0.05	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
implying	NULL
a	NULL
role	NULL
for	NULL
c-Jun	NULL
in	NULL
the	NULL
transcriptional	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

104	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
effect	NULL
elicited	NULL
by	NULL
pCMV-TAM67	NULL
indeed	NULL
involved	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
and	NULL
not	NULL
possible	NULL
regulatory	NULL
proteins	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
,	NULL
TF-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pCMV-TAM67	NULL
and	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
3xCAT	NULL
simultaneously	NULL
.	NULL

Overexpression	NULL
of	NULL
dominant	NULL
negative	NULL
c-Jun	NULL
again	NULL
strongly	NULL
inhibited	NULL
NF-	NULL
«	NULL
B-mediated	NULL
promoter	NULL
activity	NULL
(	NULL
28	NULL
+	NULL
7	NULL
%	NULL
for	NULL
pCMV-TAM67	NULL
vs	NULL
100	NULL
%	NULL
for	NULL
peDNA3	NULL
;	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
Fig	NULL
.	NULL

108	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
c-Jun	NULL
cooperates	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
activating	NULL
a	NULL
NF-	NULL
«	NULL
B-driven	NULL
promoter	NULL
element	NULL
.	NULL

Discussion	NULL
IL-6	NULL
is	NULL
a	NULL
pleiotropic	NULL
cytokine	NULL
released	NULL
from	NULL
activated	NULL
monocytes	NULL
that	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
paper	NULL
we	NULL
used	NULL
a	NULL
chemical	NULL
inhibitor	NULL
of	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
,	NULL
okadaic	NULL
acid	NULL
,	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
serine/threonine	NULL
phosphorylation	NULL
in	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
that	NULL
control	NULL
IL-6	NULL
expression	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
with	NULL
OA	NULL
resulted	NULL
in	NULL
enhanced	NULL
phosphorylation	NULL
of	NULL
ERK1	NULL
(	NULL
p44Y*	NULL
``	NULL
*	NULL
)	NULL
and	NULL
ERK2	NULL
(	NULL
p42	NULL
~	NULL
``	NULL
)	NULL
and	NULL
increased	NULL
kinase	NULL
activity	NULL
of	NULL
JNK	NULL
,	NULL
with	NULL
concomi-tantly	NULL
enhanced	NULL
IL-6	NULL
protein	NULL
secretion	NULL
,	NULL
IL-6	NULL
mRNA	NULL
,	NULL
and	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
.	NULL

Both	NULL
ERK1/2	NULL
and	NULL
JNK	NULL
belong	NULL
to	NULL
the	NULL
family	NULL
of	NULL
MAPKs	NULL
that	NULL
are	NULL
important	NULL
mediators	NULL
of	NULL
signal	NULL
transduction	NULL
from	NULL
cell	NULL
surface	NULL
receptors	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

The	NULL
three	NULL
classical	NULL
parallel	NULL
MAP	NULL
kinase	NULL
cascades	NULL
have	NULL
been	NULL
identified	NULL
to	NULL
date	NULL
are	NULL
mediated	NULL
through	NULL
ERK1/ERK2	NULL
(	NULL
p44Y*	NULL
``	NULL
~	NULL
and	NULL
p42	NULL
~	NULL
``	NULL
)	NULL
,	NULL
JNK	NULL
(	NULL
SAPK1	NULL
)	NULL
,	NULL
and	NULL
p38	NULL
(	NULL
RK	NULL
,	NULL
CSBP	NULL
,	NULL
MPK2	NULL
)	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
pretreatment	NULL
of	NULL
monocytes	NULL
with	NULL
PD98059	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
MEK1	NULL
,	NULL
the	NULL
upstream	NULL
kinase	NULL
from	NULL
ERK1/2	NULL
,	NULL
showed	NULL
an	NULL
inhibition	NULL
of	NULL
OA-induced	NULL
IL-6	NULL
protein	NULL
secretion	NULL
from	NULL
monocytes	NULL
,	NULL
which	NULL
was	NULL
not	NULL
reflected	NULL
by	NULL
a	NULL
change	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
would	NULL
implicate	NULL
involvement	NULL
of	NULL
the	NULL
MEK1/ERK1/2	NULL
pathway	NULL
in	NULL
IL-6	NULL
protein	NULL
secretion	NULL
,	NULL
this	NULL
inhibition	NULL
was	NULL
not	NULL
accomplished	NULL
by	NULL
altering	NULL
the	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
NF-KB	NULL
.	NULL

This	NULL
observation	NULL
in	NULL
monocytes	NULL
is	NULL
contradictory	NULL
to	NULL
reports	NULL
in	NULL
other	NULL
cell	NULL
systems	NULL
describing	NULL
a	NULL
close	NULL
association	NULL
between	NULL
ERK1	NULL
activity	NULL
and	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IB	NULL
protein	NULL
,	NULL
thus	NULL
leading	NULL
to	NULL
NF-KB	NULL
activation	NULL
.	NULL

Sonoda	NULL
et	NULL
al	NULL
.	NULL

,	NULL
for	NULL
instance	NULL
,	NULL
reported	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
GST	NULL
-IrB-a	NULL
@	NULL
by	NULL
OA-activated	NULL
ERK	NULL
1	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Studies	NULL
by	NULL
Schouten	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
the	NULL
mitogen-activated	NULL
90-kDa	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
(	NULL
p90	NULL
)	NULL
is	NULL
an	NULL
IxBa	NULL
kinase	NULL
(	NULL
42	NULL
)	NULL
.	NULL

p90	NULL
``	NULL
'	NULL
,	NULL
which	NULL
is	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
downstream	NULL
from	NULL
the	NULL
Raf/MEK1/ERK1/2	NULL
cascade	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
phosphorylate	NULL
IxBa	NULL
on	NULL
two	NULL
serine	NULL
residues	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
Ser'~	NULL
and	NULL
Moreover	NULL
,	NULL
in	NULL
the	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
CEM	NULL
,	NULL
overexpression	NULL
of	NULL
either	NULL
MEK	NULL
1	NULL
or	NULL
ERK1	NULL
demonstrated	NULL
constitutive	NULL
nuclear	NULL
localization	NULL
of	NULL
NF-KB	NULL
,	NULL
suggesting	NULL
involvement	NULL
of	NULL
the	NULL
classical	NULL
ERK	NULL
pathway	NULL
in	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
our	NULL
cell	NULL
system	NULL
,	NULL
however	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
OA	NULL
activates	NULL
ERK	NULL
1	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
phosphorylates	NULL
IB	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
degradation	NULL
of	NULL
IB	NULL
.	NULL

Rather	NULL
,	NULL
IxBa	NULL
is	NULL
phosphorylated	NULL
due	NULL
to	NULL
OA	NULL
stimulation	NULL
of	NULL
a	NULL
pathway	NULL
distinct	NULL
from	NULL
the	NULL
Raf-1/MEK1/ERK	NULL
pathway	NULL
.	NULL

Recently	NULL
,	NULL
two	NULL
upstream	NULL
kinases	NULL
of	NULL
IxBa	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
IKKa	NULL
and	NULL
IKK	NULL
(	NULL
IxBa	NULL
kinase	NULL
)	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
that	NULL
OA	NULL
inhibited	NULL
a	NULL
PP2A	NULL
,	NULL
which	NULL
normally	NULL
dephosphory-lates	NULL
IKKa	NULL
,	NULL
thus	NULL
leading	NULL
to	NULL
enhanced	NULL
IxBa	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
and	NULL
enhanced	NULL
NF-KB	NULL
binding	NULL
activity	NULL
(	NULL
45	NULL
)	NULL
.	NULL

This	NULL
signaling	NULL
route	NULL
may	NULL
,	NULL
independently	NULL
from	NULL
the	NULL
Raf-1/MEK1/ERK1/2	NULL
pathway	NULL
,	NULL
account	NULL
for	NULL
the	NULL
enhanced	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
as	NULL
observed	NULL
after	NULL
OA	NULL
stimulation	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Although	NULL
the	NULL
Raf-1/MEK1/ERK1/2	NULL
pathway	NULL
did	NULL
not	NULL
affect	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
we	NULL
clearly	NULL
demonstrated	NULL
that	NULL
overexpression	NULL
of	NULL
an	NULL
inactive	NULL
mutant	NULL
of	NULL
Raf-1	NULL
inhibited	NULL
NF-	NULL
«	NULL
B-mediated	NULL
IL-6	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
ERK	NULL
pathway	NULL
serves	NULL
as	NULL
an	NULL
additional	NULL
signaling	NULL
pathway	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
IB	NULL
degradation	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
DNA	NULL
binding	NULL
,	NULL
but	NULL
is	NULL
required	NULL
for	NULL
NF-KB	NULL
transcriptional	NULL
activation	NULL
by	NULL
OA	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
observation	NULL
are	NULL
previous	NULL
reports	NULL
describing	NULL
additional	NULL
regulatory	NULL
mechanisms	NULL
,	NULL
other	NULL
than	NULL
modulating	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
properties	NULL
,	NULL
that	NULL
enhance	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-xB	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
serine	NULL
phosphorylation	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
a	NULL
regulatory	NULL
step	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
reported	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
our	NULL
setting	NULL
OA	NULL
was	NULL
capable	NULL
of	NULL
enhancing	NULL
p65-mediated	NULL
transcription	NULL
from	NULL
the	NULL
GALA	NULL
promoter	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
contains	NULL
at	NULL
least	NULL
two	NULL
strong	NULL
transactivation	NULL
domains	NULL
within	NULL
its	NULL
C	NULL
terminus	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
first	NULL
domain	NULL
,	NULL
TA1l	NULL
,	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
last	NULL
30	NULL
amino	NULL
acids	NULL
of	NULL
p65	NULL
,	NULL
whereas	NULL
TAZ	NULL
comprises	NULL
the	NULL
adjacent	NULL
90	NULL
amino	NULL
acids	NULL
.	NULL

Schmitz	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
phosphorylation	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
defined	NULL
region	NULL
within	NULL
the	NULL
TAZ	NULL
domain	NULL
were	NULL
stimulated	NULL
by	NULL
phorbol	NULL
ester	NULL
treatment	NULL
of	NULL
cells	NULL
,	NULL
and	NULL
thus	NULL
augmented	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
46	NULL
)	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
was	NULL
shown	NULL
to	NULL
phosphorylate	NULL
p65	NULL
at	NULL
a	NULL
serine	NULL
residue	NULL
276	NULL
,	NULL
thus	NULL
increasing	NULL
the	NULL
transactivational	NULL
capacity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
without	NULL
affecting	NULL
nuclear	NULL
translocation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
as	NULL
a	NULL
result	NULL
of	NULL
protein	NULL
kinase	NULL
A-mediated	NULL
phosphorylation	NULL
,	NULL
p65	NULL
creates	NULL
a	NULL
site	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
transcriptional	NULL
coactivator	NULL
CBP/p300	NULL
,	NULL
which	NULL
results	NULL
in	NULL
enhanced	NULL
transcriptional	NULL
activity	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
fibroblasts	NULL
and	NULL
hepatoma	NULL
cells	NULL
IL-1-mediated	NULL
NF-KB	NULL
activation	NULL
was	NULL
accompanied	NULL
by	NULL
casein	NULL
kinase	NULL
II-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
on	NULL
serine	NULL
residues	NULL
(	NULL
50	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
results	NULL
of	NULL
our	NULL
experiments	NULL
showing	NULL
that	NULL
NF-KB	NULL
transactivation	NULL
capacity	NULL
,	NULL
but	NULL
not	NULL
DNA	NULL
binding	NULL
,	NULL
is	NULL
dependent	NULL
on	NULL
serine	NULL
kinase	NULL
activity	NULL
.	NULL

In	NULL
our	NULL
experimental	NULL
setting	NULL
,	NULL
however	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
whether	NULL
the	NULL
MAPK-dependent	NULL
phosphorylation	NULL
effectively	NULL
takes	NULL
place	NULL
on	NULL
the	NULL
p65	NULL
subunit	NULL
itself	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
JNK	NULL
pathway	NULL
also	NULL
mediated	NULL
the	NULL
transcriptional	NULL
potential	NULL
of	NULL
NF-KB	NULL
,	NULL
both	NULL
in	NULL
context	NULL
of	NULL
the	NULL
IL-6	NULL
promoter	NULL
and	NULL
when	NULL
bound	NULL
to	NULL
individual	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
JNK	NULL
protein	NULL
kinases	NULL
phosphorylate	NULL
the	NULL
NH2-terminal	NULL
activation	NULL
domain	NULL
of	NULL
c-Jun	NULL
on	NULL
Ser	NULL
and	NULL
Ser'*	NULL
,	NULL
causing	NULL
increased	NULL
c-Jun	NULL
transcriptional	NULL
activity	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Results	NULL
from	NULL
cotransfection	NULL
studies	NULL
applying	NULL
plLéluc	NULL
(	NULL
-122	NULL
)	NULL
or	NULL
p	NULL
(	NULL
NF-	NULL
«	NULL
kB	NULL
)	NULL
3xCAT	NULL
,	NULL
both	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
only	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
pCMV-TAM67	NULL
,	NULL
the	NULL
NH-terminally	NULL
truncated	NULL
dominant	NULL
negative	NULL
c-Jun	NULL
,	NULL
suggest	NULL
c-Jun/NF-	NULL
«	NULL
B	NULL
protein/	NULL
protein	NULL
interaction	NULL
.	NULL

pCMV-TAM67	NULL
specifically	NULL
binds	NULL
to	NULL
leucine	NULL
zippers	NULL
of	NULL
endogenous	NULL
Jun	NULL
or	NULL
Fos	NULL
family	NULL
proteins	NULL
,	NULL
forming	NULL
low	NULL
activity	NULL
AP-1	NULL
complexes	NULL
(	NULL
51	NULL
)	NULL
.	NULL

pCMV-TAM67	NULL
binding	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
render	NULL
the	NULL
c-Jun	NULL
and	NULL
the	NULL
c-Fos	NULL
bZip	NULL
domains	NULL
unavailable	NULL
to	NULL
p65	NULL
,	NULL
which	NULL
requires	NULL
the	NULL
bZip	NULL
domain	NULL
for	NULL
interaction	NULL
.	NULL

Al-ternatively	NULL
,	NULL
pCMV-TAM67	NULL
may	NULL
interact	NULL
via	NULL
its	NULL
bZip	NULL
domain	NULL
with	NULL
p65	NULL
,	NULL
rendering	NULL
the	NULL
p65	NULL
unavailable	NULL
to	NULL
interact	NULL
with	NULL
c-Jun	NULL
or	NULL
c-Fos	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
pCMV-TAM67	NULL
dramatically	NULL
impaired	NULL
«	NULL
B-driven	NULL
promoter	NULL
activity	NULL
,	NULL
strongly	NULL
suggesting	NULL
that	NULL
either	NULL
c-Jun	NULL
or	NULL
c-Fos	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
transactivation	NULL
capacity	NULL
of	NULL
NF-KB	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
that	NULL
cross-interaction	NULL
of	NULL
c-Jun	NULL
or	NULL
c-Fos	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
p65	NULL
leads	NULL
to	NULL
synergized	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transactivation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
a	NULL
human	NULL
keratinocyte	NULL
progression	NULL
model	NULL
TAM67	NULL
was	NULL
also	NULL
found	NULL
to	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Taking	NULL
into	NULL
account	NULL
that	NULL
1	NULL
)	NULL
the	NULL
JNK	NULL
pathway	NULL
affects	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
,	NULL
and	NULL
2	NULL
)	NULL
JNK	NULL
is	NULL
the	NULL
main	NULL
activator	NULL
of	NULL
c-Jun	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
the	NULL
c-Jun	NULL
protein	NULL
results	NULL
in	NULL
maximal	NULL
transactivation	NULL
.	NULL

Since	NULL
serine	NULL
kinase	NULL
activity	NULL
is	NULL
required	NULL
4901	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
c-Jun	NULL
by	NULL
JNK	NULL
,	NULL
the	NULL
inhibitory	NULL
effect	NULL
mediated	NULL
by	NULL
H7	NULL
could	NULL
be	NULL
the	NULL
consequence	NULL
of	NULL
impaired	NULL
c-Jun	NULL
phosphorylation	NULL
by	NULL
JNK	NULL
.	NULL

In	NULL
concordance	NULL
,	NULL
Berra	NULL
and	NULL
co-workers	NULL
demonstrated	NULL
that	NULL
protein	NULL
kinase	NULL
CZ	NULL
,	NULL
a	NULL
downstream	NULL
substrate	NULL
of	NULL
Ras	NULL
,	NULL
triggers	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
kinases	NULL
and	NULL
suggested	NULL
that	NULL
MEK1	NULL
and	NULL
ERK1/2	NULL
may	NULL
also	NULL
participate	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
enhancing	NULL
the	NULL
AP-1/NF-	NULL
«	NULL
B	NULL
cross-coupling	NULL
mechanism	NULL
(	NULL
53	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
recent	NULL
study	NULL
by	NULL
Min	NULL
et	NULL
al	NULL
.	NULL

showed	NULL
that	NULL
transient	NULL
overexpression	NULL
of	NULL
an	NULL
N-terminal-truncated	NULL
c-Jun	NULL
or	NULL
a	NULL
catalytically	NULL
inactive	NULL
JNK	NULL
inhibited	NULL
TNF-induced	NULL
transcription	NULL
of	NULL
the	NULL
E-selectin	NULL
but	NULL
not	NULL
of	NULL
a	NULL
«	NULL
B-promoter	NULL
reporter	NULL
gene	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
c-Jun	NULL
augments	NULL
«	NULL
B-dependent	NULL
transcription	NULL
may	NULL
be	NULL
cell	NULL
type	NULL
and	NULL
stimulus	NULL
specific	NULL
.	NULL

We	NULL
can	NULL
not	NULL
exclude	NULL
that	NULL
in	NULL
our	NULL
cell	NULL
system	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
pathways	NULL
,	NULL
the	NULL
p38	NULL
signaling	NULL
route	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

In	NULL
studies	NULL
by	NULL
vanden	NULL
Berghe	NULL
et	NULL
al	NULL
.	NULL

TNF-induced	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transcription	NULL
,	NULL
but	NULL
not	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
,	NULL
appeared	NULL
dependent	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
p38/RK	NULL
pathway	NULL
in	NULL
the	NULL
mouse	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
L929sA	NULL
(	NULL
55	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
signaling	NULL
modules	NULL
involved	NULL
in	NULL
IL-6	NULL
gene	NULL
regulation	NULL
are	NULL
not	NULL
only	NULL
cell	NULL
type	NULL
specific	NULL
,	NULL
but	NULL
also	NULL
depend	NULL
on	NULL
the	NULL
stimulatory	NULL
signal	NULL
.	NULL

More	NULL
detailed	NULL
study	NULL
is	NULL
required	NULL
to	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
additional	NULL
MAPK	NULL
pathways	NULL
in	NULL
IL-6	NULL
gene	NULL
expression	NULL
.	NULL

Until	NULL
recently	NULL
limited	NULL
data	NULL
existed	NULL
regarding	NULL
the	NULL
way	NULL
activated	NULL
kinases	NULL
might	NULL
be	NULL
dephosphorylated	NULL
and	NULL
inactivated	NULL
.	NULL

Since	NULL
the	NULL
MAP	NULL
kinases	NULL
ERK1/ERK2	NULL
and	NULL
JNK	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-6	NULL
expression	NULL
,	NULL
the	NULL
balance	NULL
of	NULL
MAPK	NULL
kinase	NULL
and	NULL
MAPK	NULL
phosphatase	NULL
activities	NULL
determines	NULL
the	NULL
state	NULL
of	NULL
activation	NULL
of	NULL
monocytes	NULL
.	NULL

Three	NULL
mammalian	NULL
MAPK	NULL
phosphatases	NULL
have	NULL
been	NULL
identified	NULL
until	NULL
now	NULL
,	NULL
CL100	NULL
,	NULL
PAC-1	NULL
,	NULL
and	NULL
Pyst-1	NULL
(	NULL
56-59	NULL
)	NULL
.	NULL

Although	NULL
their	NULL
occurrence	NULL
in	NULL
monocytes	NULL
and	NULL
leukemic	NULL
cell	NULL
lines	NULL
and	NULL
the	NULL
substrate	NULL
specificity	NULL
of	NULL
these	NULL
PPases	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
resolved	NULL
,	NULL
they	NULL
may	NULL
have	NULL
important	NULL
functional	NULL
roles	NULL
in	NULL
mediating	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
OA-induced	NULL
IL-6	NULL
gene	NULL
activation	NULL
in	NULL
monocytes	NULL
is	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
JNK	NULL
and	NULL
ERK1/2	NULL
pathways	NULL
.	NULL

The	NULL
ERK1/2	NULL
pathway	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
specifically	NULL
involved	NULL
in	NULL
enhancing	NULL
the	NULL
transactivational	NULL
capacity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Both	NULL
pathways	NULL
may	NULL
provide	NULL
for	NULL
serine	NULL
kinase	NULL
activity	NULL
and	NULL
c-Jun	NULL
activation	NULL
,	NULL
which	NULL
were	NULL
shown	NULL
to	NULL
enhance	NULL
«	NULL
B-driven	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

1990	NULL
.	NULL

Interleukin	NULL
6	NULL
:	NULL
an	NULL
overview	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:253	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Natsuka	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
interleukin-6	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-IL6	NULL
.	NULL

Ciba	NULL
Found	NULL
.	NULL

Symp	NULL
.	NULL

167:47	NULL
.	NULL

3	NULL
.	NULL

Dokter	NULL
,	NULL
W.	NULL
H.	NULL
A.	NULL
,	NULL
S.	NULL
B.	NULL
Koopmans	NULL
,	NULL
and	NULL
E.	NULL
Vellenga	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
of	NULL
IL-10	NULL
and	NULL
IL-4	NULL
on	NULL
LPS-induced	NULL
transcription	NULL
factors	NULL
(	NULL
AP-1	NULL
,	NULL
NF-IL6	NULL
and	NULL
NF-KB	NULL
)	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
IL-6	NULL
regulation	NULL
.	NULL

Leukemia	NULL
10:1308	NULL
.	NULL

4	NULL
.	NULL

Tuyt	NULL
,	NULL
L.	NULL
M.	NULL
L.	NULL
,	NULL
H.	NULL
De	NULL
Wit	NULL
,	NULL
S.	NULL
B.	NULL
Koopmans	NULL
,	NULL
S.	NULL
J.	NULL
Sierdsema	NULL
,	NULL
and	NULL
E.	NULL
Vellenga	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
of	NULL
IL-3	NULL
and	NULL
LPS	NULL
on	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-6	NULL
mRNA	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Hematol	NULL
.	NULL

92:521	NULL
.	NULL

5	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Mitomo	NULL
,	NULL
T.	NULL
Watanabe	NULL
,	NULL
S.	NULL
I.	NULL
Okamoto	NULL
,	NULL
and	NULL
K.	NULL
I.	NULL
Yamamoto	NULL
.	NULL

1990	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
NF-KB	NULL
like	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
interleukin-6	NULL
gene	NULL
by	NULL
inflammatory	NULL
lymphokines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:561	NULL
.	NULL

6	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327	NULL
.	NULL

7	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
J.	NULL
X.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
Vileek	NULL
.	NULL

1990	NULL
.	NULL

Interleukin-6	NULL
induction	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
in	NULL
human	NULL
fibroblasts	NULL
involves	NULL
activation	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
a	NULL
kB-like	NULL
sequence	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3818	NULL
.	NULL

8	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1997	NULL
.	NULL

NF-IL6	NULL
and	NULL
NF-KB	NULL
in	NULL
cytokine	NULL
gene	NULL
regulation	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

65:1	NULL
.	NULL

9	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
:	NULL
structure-function	NULL
relationship	NULL
of	NULL
its	NULL
protein	NULL
subunits	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

290:297	NULL
.	NULL

10	NULL
.	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1990	NULL
.	NULL

Transcription	NULL
factors	NULL
NFB-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
syn-ergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10193	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
4902	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

Dendorfer	NULL
,	NULL
U.	NULL
,	NULL
P.	NULL
Octtgen	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Libermann	NULL
.	NULL

1994	NULL
.	NULL

Multiple	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
interleukin-6	NULL
gene	NULL
mediate	NULL
induction	NULL
by	NULL
prostaglandins	NULL
,	NULL
cyclic	NULL
AMP	NULL
,	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4443	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Mitogen-activated	NULL
protein	NULL
kinase	NULL
cascades	NULL
and	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:402	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1996	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
by	NULL
MAP	NULL
kinase	NULL
cascades	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:205	NULL
.	NULL

Ghoda	NULL
,	NULL
L.	NULL
,	NULL
X.	NULL
Lin	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
90-kDa	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
(	NULL
pp90®	NULL
``	NULL
~	NULL
)	NULL
phosphorylates	NULL
the	NULL
N-terminal	NULL
regulatory	NULL
domain	NULL
of	NULL
and	NULL
stimulates	NULL
its	NULL
degradation	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:21281	NULL
.	NULL

Briant	NULL
,	NULL
L.	NULL
,	NULL
V.	NULL
Robert-Hebmann	NULL
,	NULL
V.	NULL
Sivan	NULL
,	NULL
A.	NULL
Brunet	NULL
,	NULL
J.	NULL
Pouyssegur	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1998	NULL
.	NULL

Involvement	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
module	NULL
in	NULL
HIV-mediated	NULL
CD4	NULL
signals	NULL
controlling	NULL
activation	NULL
of	NULL
nuclear	NULL
factor-kB	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:1875	NULL
.	NULL

Coso	NULL
,	NULL
O	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Chiariello	NULL
,	NULL
J.	NULL
C.	NULL
Yu	NULL
,	NULL
H.	NULL
Teramoto	NULL
,	NULL
P.	NULL
Crespo	NULL
,	NULL
N.	NULL
Xu	NULL
,	NULL
T.	NULL
Miki	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Gutkind	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
small	NULL
GTP-binding	NULL
proteins	NULL
Racl	NULL
and	NULL
Cdc42	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
JINK/SAPK	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
81:1137	NULL
.	NULL

Dérijard	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
L-H.	NULL
Wu	NULL
,	NULL
T.	NULL
Barrett	NULL
,	NULL
B.	NULL
Su	NULL
,	NULL
T.	NULL
Deng	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1994	NULL
.	NULL

JNK1	NULL
:	NULL
a	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
76:1025	NULL
.	NULL

Fanger	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
P.	NULL
Gerwins	NULL
,	NULL
C.	NULL
Widmann	NULL
,	NULL
M.	NULL
B.	NULL
Jarpe	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Johnson	NULL
.	NULL

1997	NULL
.	NULL

MEKKs	NULL
,	NULL
GCKs	NULL
,	NULL
MLKs	NULL
,	NULL
PAKs	NULL
,	NULL
TAKs	NULL
,	NULL
and	NULL
tpls	NULL
:	NULL
upstream	NULL
regulators	NULL
of	NULL
the	NULL
c-Jun	NULL
amino-terminal	NULL
kinases	NULL
?	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

7:67	NULL
.	NULL

Ho	NULL
,	NULL
H.-Y	NULL
.	NULL

,	NULL
H.-H.	NULL
Lee	NULL
,	NULL
and	NULL
M.-Z	NULL
.	NULL

Lai	NULL
.	NULL

1997	NULL
.	NULL

Overexpression	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
kinase	NULL
reversed	NULL
cAMP	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:222	NULL
.	NULL

Lee	NULL
,	NULL
F.	NULL
S.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
Z.	NULL
J.	NULL
Chen	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
IxBa	NULL
kinase	NULL
complex	NULL
by	NULL
MEKK1	NULL
,	NULL
a	NULL
kinase	NULL
of	NULL
the	NULL
JNK	NULL
pathway	NULL
.	NULL

Cell	NULL
88:213	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
F.	NULL
B.	NULL
Holmes	NULL
,	NULL
and	NULL
Y.	NULL
Tsukitani	NULL
.	NULL

1990	NULL
.	NULL

Okadaic	NULL
acid	NULL
:	NULL
a	NULL
new	NULL
probe	NULL
for	NULL
the	NULL
study	NULL
of	NULL
cellular	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

15:98	NULL
.	NULL

Sung	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Walters	NULL
.	NULL

1993	NULL
.	NULL

Stimulation	NULL
of	NULL
interleukin-1	NULL
@	NULL
and	NULL
interleukin-1	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
by	NULL
protein	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
inhib-itors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:5802	NULL
.	NULL

Sung	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Walters	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Fu	NULL
.	NULL

1992	NULL
.	NULL

Stimulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
by	NULL
inhibitors	NULL
of	NULL
protein	NULL
phosphatase	NULL
1	NULL
and	NULL
2A	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:897	NULL
.	NULL

Kitamura	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Tange	NULL
,	NULL
T.	NULL
Terasawa	NULL
,	NULL
S.	NULL
Chiba	NULL
,	NULL
T.	NULL
Kuwaki	NULL
,	NULL
K.	NULL
Miyagawa	NULL
,	NULL
Y.-F.	NULL
Piao	NULL
,	NULL
K.	NULL
Miyazono	NULL
,	NULL
A.	NULL
Urabe	NULL
,	NULL
and	NULL
F.	NULL
Takaku	NULL
.	NULL

1989	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
unique	NULL
human	NULL
cell	NULL
line	NULL
that	NULL
proliferates	NULL
dependently	NULL
on	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
erythropoietin	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

140:323	NULL
.	NULL

Alessi	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
A.	NULL
Cuenda	NULL
,	NULL
P.	NULL
Cohen	NULL
,	NULL
D.	NULL
T.	NULL
Dudley	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Saltiel	NULL
.	NULL

1995	NULL
.	NULL

PDO98059	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:27489	NULL
.	NULL

Dokter	NULL
,	NULL
W.	NULL
H.	NULL
A.	NULL
,	NULL
M.	NULL
T.	NULL
Esselink	NULL
,	NULL
M.	NULL
R.	NULL
Halie	NULL
,	NULL
and	NULL
E.	NULL
Vellenga	NULL
.	NULL

1993	NULL
.	NULL

Interleu-kin-4	NULL
inhibits	NULL
the	NULL
lipopolysaccharide-induced	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
messenger	NULL
RNA	NULL
and	NULL
activator	NULL
protein-1	NULL
binding	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
81:337	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miiller	NULL
,	NULL
and	NULL
W.	NULL
Scaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini	NULL
extracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Smith	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
K.	NULL
S.	NULL
Johnson	NULL
.	NULL

1988	NULL
.	NULL

Single-step	NULL
purification	NULL
of	NULL
polypeptides	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
as	NULL
fusions	NULL
with	NULL
glutathione	NULL
S-transferase	NULL
.	NULL

Gene	NULL
67:31	NULL
.	NULL

Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Datta	NULL
,	NULL
E.	NULL
Rubin	NULL
,	NULL
T.	NULL
Nakamura	NULL
,	NULL
R.	NULL
Hass	NULL
,	NULL
and	NULL
D.	NULL
Kufe	NULL
.	NULL

1992	NULL
.	NULL

Regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

3:391	NULL
.	NULL

Hurme	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
Matikainen	NULL
.	NULL

1993	NULL
.	NULL

Okadaic	NULL
acid	NULL
,	NULL
a	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
enhances	NULL
the	NULL
phorbol	NULL
ester-induced	NULL
interleukin-1f3	NULL
expression	NULL
via	NULL
an	NULL
AP-l-me-diated	NULL
mechanism	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

38:570	NULL
.	NULL

Amaral	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
A.	NULL
M.	NULL
Casillas	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Nel	NULL
.	NULL

1993	NULL
.	NULL

Contrasting	NULL
effects	NULL
of	NULL
two	NULL
tumour	NULL
promoters	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
and	NULL
okadaic	NULL
acid	NULL
,	NULL
on	NULL
T-cell	NULL
responses	NULL
and	NULL
activation	NULL
of	NULL
p42	NULL
MAP-kinase/ERK-2	NULL
.	NULL

Immunology	NULL
79:24	NULL
.	NULL

Casillas	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
M.	NULL
C.	NULL
Amaral	NULL
,	NULL
S.	NULL
Chegini-Farahani	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Nel	NULL
.	NULL

1993	NULL
.	NULL

Okadaic	NULL
acid	NULL
activates	NULL
p42	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAP	NULL
kinase	NULL
:	NULL
ERK-2	NULL
)	NULL
in	NULL
B-lymphocytes	NULL
but	NULL
inhibits	NULL
rather	NULL
than	NULL
augments	NULL
cellular	NULL
proliferation	NULL
:	NULL
contrast	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

290:545	NULL
.	NULL

Hardwick	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
L.	NULL
Hegyi	NULL
,	NULL
K.	NULL
Clare	NULL
,	NULL
N.	NULL
S.	NULL
Law	NULL
,	NULL
K.	NULL
L.	NULL
Carpenter	NULL
,	NULL
M.	NULL
J.	NULL
Mitchinson	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Skepper	NULL
.	NULL

1996	NULL
.	NULL

Apoptosis	NULL
in	NULL
human	NULL
monocyte-macrophages	NULL
exposed	NULL
to	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

179:294	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
he	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805	NULL
.	NULL

Schaap	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
van	NULL
der	NULL
Wal	NULL
,	NULL
L.	NULL
R.	NULL
Howe	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
van	NULL
Bitterswijk	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
raf	NULL
blocks	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
activation	NULL
by	NULL
growth	NULL
factors	NULL
and	NULL
oncogenic	NULL
p21	NULL
ras	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:20232	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

ERK1/2	NULL
,	NULL
JNK	NULL
,	NULL
AND	NULL
c-Jun	NULL
IN	NULL
NF-	NULL
«	NULL
B-MEDIATED	NULL
IL-6	NULL
EXPRESSION	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
B.	NULL
Dérijard	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Davis	NULL
.	NULL

1995	NULL
.	NULL

Transcription	NULL
factor	NULL
ATF2	NULL
regulation	NULL
by	NULL
the	NULL
JNK	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Science	NULL
267:389	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1993	NULL
.	NULL

Cross-coupling	NULL
of	NULL
the	NULL
NF-B	NULL
p65	NULL
and	NULL
Fos/Jun	NULL
transcription	NULL
factors	NULL
produces	NULL
potentiated	NULL
biological	NULL
function	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3879	NULL
.	NULL

Brown	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
M.	NULL
W.	NULL
Albers	NULL
,	NULL
T.	NULL
B.	NULL
Shin	NULL
,	NULL
K.	NULL
Ichikawa	NULL
,	NULL
C.	NULL
T.	NULL
Keith	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Schreiber	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
mammalian	NULL
protein	NULL
targeted	NULL
by	NULL
Gl-arresting	NULL
rapa-mycin-receptor	NULL
complex	NULL
.	NULL

Nature	NULL
369:756	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
,	NULL
Z.	NULL
G.	NULL
Liu	NULL
,	NULL
and	NULL
Zandi	NULL
,	NULL
E.	NULL
1997	NULL
.	NULL

AP-1	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:240	NULL
.	NULL

Hirano	NULL
,	NULL
T.	NULL
1998	NULL
.	NULL

Interleukin	NULL
6	NULL
and	NULL
its	NULL
receptor	NULL
:	NULL
ten	NULL
years	NULL
later	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:249	NULL
.	NULL

Sonoda	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Kashahara	NULL
,	NULL
Y.	NULL
Yamaguchi	NULL
,	NULL
K.	NULL
Kuno	NULL
,	NULL
K.	NULL
Matsishima	NULL
,	NULL
and	NULL
N.	NULL
Mukaida	NULL
.	NULL

1997	NULL
.	NULL

Stimulation	NULL
of	NULL
interleukin-8	NULL
production	NULL
by	NULL
okadaic	NULL
acid	NULL
and	NULL
vanadate	NULL
in	NULL
a	NULL
human	NULL
promyelocyte	NULL
cell	NULL
line	NULL
,	NULL
an	NULL
HL-60	NULL
subline	NULL
:	NULL
possible	NULL
role	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
on	NULL
the	NULL
okadaic	NULL
acid-induced	NULL
NF-KB	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:15366	NULL
.	NULL

Schouten	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
A.	NULL
C.	NULL
O.	NULL
Vertegaal	NULL
,	NULL
S.	NULL
T.	NULL
Whiteside	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
M.	NULL
Toebes	NULL
,	NULL
J.	NULL
C.	NULL
Dorsman	NULL
,	NULL
A.	NULL
J.	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
and	NULL
A.	NULL
Zantema	NULL
.	NULL

1997	NULL
.	NULL

I	NULL
«	NULL
Ba	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
mitogen-activated	NULL
90	NULL
kDa	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3133	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
H.	NULL
Zhu	NULL
,	NULL
B.	NULL
W.	NULL
Murray	NULL
,	NULL
A.	NULL
Shevchenko	NULL
,	NULL
B.	NULL
L.	NULL
Bennett	NULL
,	NULL
J.	NULL
W.	NULL
Li	NULL
,	NULL
D.	NULL
B	NULL
.	NULL

Young	NULL
,	NULL
M.	NULL
Barbosa	NULL
,	NULL
M.	NULL
Mann	NULL
,	NULL
A.	NULL
Manning	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

IKK-1	NULL
and	NULL
IKK-2	NULL
:	NULL
cytokine-activated	NULL
IB	NULL
kinases	NULL
essential	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Science	NULL
278:860	NULL
.	NULL

Woronicz	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
X.	NULL
Gao	NULL
,	NULL
Z.	NULL
Cao	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1997	NULL
.	NULL

IB	NULL
kinase-B	NULL
:	NULL
NF-KB	NULL
activation	NULL
and	NULL
complex	NULL
formation	NULL
with	NULL
IB	NULL
kinase-a	NULL
and	NULL
NIK	NULL
.	NULL

Science	NULL
278:866	NULL
.	NULL

Zandi	NULL
,	NULL
E.	NULL
,	NULL
D.	NULL
M.	NULL
Rothwarf	NULL
,	NULL
M.	NULL
Delhase	NULL
,	NULL
M.	NULL
Hayakawa	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IkB	NULL
kinase	NULL
complex	NULL
(	NULL
IKK	NULL
)	NULL
contains	NULL
two	NULL
kinase	NULL
subunits	NULL
,	NULL
IKKa	NULL
and	NULL
IKK	NULL
,	NULL
necessary	NULL
for	NULL
IxB	NULL
phosphorylation	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Cell	NULL
91:243	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
M.	NULL
A.	NULL
dos	NULL
Santos	NULL
Silva	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1995	NULL
.	NULL

Transactivation	NULL
domain	NULL
2	NULL
(	NULL
TAZ	NULL
)	NULL
of	NULL
p65	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
similarity	NULL
to	NULL
TA1	NULL
and	NULL
phorbol	NULL
ester-stimu-lated	NULL
activity	NULL
and	NULL
phosphorylation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:15576	NULL
.	NULL

Zhong	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Su¥Yang	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
IxB-associated	NULL
PKAc	NULL
subunit	NULL
through	NULL
a	NULL
cyclic	NULL
AMP-independent	NULL
mechanism	NULL
.	NULL

Cell	NULL
89:413	NULL
.	NULL

Gerritsen	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
A.	NULL
S.	NULL
Neish	NULL
,	NULL
S.	NULL
Moore	NULL
,	NULL
Y.	NULL
Shi	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1997	NULL
.	NULL

CREB-binding	NULL
protein/p300	NULL
are	NULL
transcriptional	NULL
coactivators	NULL
of	NULL
p65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:2927	NULL
.	NULL

Zhong	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Voll	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1998	NULL
.	NULL

Phosphorylation	NULL
of	NULL
NF-KB	NULL
p65	NULL
regulates	NULL
its	NULL
transcriptional	NULL
activity	NULL
.	NULL

In	NULL
Keystone	NULL
Symposia	NULL
on	NULL
Specificity	NULL
in	NULL
Signal	NULL
Trans-duction	NULL
.	NULL

No	NULL
.	NULL

008	NULL
.	NULL

Bird	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
K.	NULL
Schooley	NULL
,	NULL
S.	NULL
K.	NULL
Dower	NULL
,	NULL
H.	NULL
Hagen	NULL
,	NULL
and	NULL
G.	NULL
D.	NULL
Virca	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
nuclear	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
by	NULL
interleukin-1	NULL
is	NULL
accompanied	NULL
by	NULL
casein	NULL
kinase	NULL
II-mediated	NULL
phosphorylation	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:32606	NULL
.	NULL

Brown	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
T.	NULL
K.	NULL
Chen	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Birrer	NULL
.	NULL

1994	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
of	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
c-Jun	NULL
.	NULL

Oncogene	NULL
9:791	NULL
.	NULL

Li	NULL
,	NULL
J.-J	NULL
.	NULL

,	NULL
M.	NULL
H.	NULL
Vousden	NULL
,	NULL
R.	NULL
Schlegel	NULL
,	NULL
and	NULL
N.	NULL
H.	NULL
Colburn	NULL
.	NULL

1996	NULL
.	NULL

AP-1	NULL
and	NULL
NF-KB	NULL
transactivation	NULL
in	NULL
E6/E7	NULL
immortalized	NULL
human	NULL
keratinocytes	NULL
.	NULL

Proc	NULL
.	NULL

Am	NULL
.	NULL

Assoc	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

37:531	NULL
.	NULL

Berra	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
S.	NULL
Frutos	NULL
,	NULL
M.	NULL
M.	NULL
Munico	NULL
,	NULL
P.	NULL
Sanchez	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
MEK	NULL
and	NULL
MAPK	NULL
during	NULL
signal	NULL
transduction	NULL
by	NULL
protein	NULL
kinase	NULL
CL	NULL
EMBO	NULL
J	NULL
.	NULL

14:6157	NULL
.	NULL

Min	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1997	NULL
.	NULL

TNF	NULL
initiates	NULL
E-selectin	NULL
transcription	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
through	NULL
parallel	NULL
TRAF-NF-KB	NULL
and	NULL
TRAF-RAC/CDC42-JNK-c-Jun/ATF2	NULL
pathways	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3508	NULL
.	NULL

Vanden	NULL
Berghe	NULL
,	NULL
W.	NULL
,	NULL
S.	NULL
Plaisance	NULL
,	NULL
E.	NULL
Boone	NULL
,	NULL
K.	NULL
De	NULL
Bosscher	NULL
,	NULL
M.	NULL
L.	NULL
Schmitz	NULL
,	NULL
W.	NULL
Fiers	NULL
,	NULL
and	NULL
G.	NULL
Hacgeman	NULL
.	NULL

1998.	NULL
p38	NULL
and	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
are	NULL
required	NULL
for	NULL
nuclear	NULL
factor-kB	NULL
p65	NULL
transactivation	NULL
mediated	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:3285	NULL
.	NULL

Keyse	NULL
,	NULL
S.	NULL
M.	NULL
1995	NULL
.	NULL

An	NULL
emerging	NULL
family	NULL
of	NULL
dual	NULL
specificity	NULL
MAP	NULL
kinase	NULL
phos-phatases	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1265:152	NULL
.	NULL

Groom	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Sneddon	NULL
,	NULL
D.	NULL
R.	NULL
Alessi	NULL
,	NULL
S.	NULL
Dowd	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Keyse	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
MAP	NULL
,	NULL
SAP	NULL
and	NULL
RK/p38	NULL
kinases	NULL
by	NULL
Pystl	NULL
,	NULL
a	NULL
novel	NULL
cytosolic	NULL
dual-specificity	NULL
phosphatase	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:3621	NULL
.	NULL

Ishibashi	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
P.	NULL
Bottaro	NULL
,	NULL
P.	NULL
Michieli	NULL
,	NULL
C.	NULL
A.	NULL
Kelley	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Aaronson	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
dual	NULL
specificity	NULL
phosphatase	NULL
induced	NULL
by	NULL
serum	NULL
stimulation	NULL
and	NULL
heat	NULL
shock	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:29897	NULL
.	NULL

Rohan	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
P.	NULL
Davis	NULL
,	NULL
C.	NULL
A.	NULL
Moskaluk	NULL
,	NULL
M.	NULL
Kerans	NULL
,	NULL
H.	NULL
Krutzsch	NULL
,	NULL
U.	NULL
Sicbenlist	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

1993	NULL
.	NULL

PAC-1	NULL
:	NULL
a	NULL
mitogen-induced	NULL
nuclear	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

Science	NULL
259:1763	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
/310°	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

